Main Research Project:Doctorate in Clinical Psychology by Grozdziej, Ania












Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.






Doctorate in Clinical Psychology:  

































Research Portfolio Submitted in Part 
Fulfilment of the requirements for the 
Degree of Doctorate in Clinical 
Psychology 
 
Anna Ewa Grozdziej 
 
Doctorate in Clinical Psychology 
 
University of Bath 





Attention is drawn to the fact that copyright of this thesis rests with the 
author. A copy of this thesis has been supplied on condition that anyone 
who consults it is understood to recognise that its copyright rests with 
the author and that they must not copy it or use material from it except 
as permitted by law or with the consent of the author. 
 
RESTRICTIONS ON USE 
This thesis may be made available for consultation within the University 
Library and may be photocopied or lent to other libraries for the 
purposes of consultation with effect from …………………… 
 















Main research paper 
 
5381 































Table of Contents 
Critical review of the literature paper .................................................................................... 6 
Abstract .................................................................................................................................. 7 
Introduction ............................................................................................................................ 8 
Methods ................................................................................................................................ 11 
Results .................................................................................................................................. 14 
Discussion ............................................................................................................................ 26 
References ............................................................................................................................ 31 
Service Improvement Project ............................................................................................... 36 
Abstract ................................................................................................................................ 37 
Introduction .......................................................................................................................... 37 
Method ................................................................................................................................. 40 
Results .................................................................................................................................. 43 
Discussion ............................................................................................................................ 51 
Recommendations ................................................................................................................ 53 
Summary and conclusion ..................................................................................................... 56 
References ............................................................................................................................ 57 
Main research project paper ................................................................................................. 60 
Abstract ................................................................................................................................ 61 
Introduction .......................................................................................................................... 62 
Methods ................................................................................................................................ 66 
Measures .............................................................................................................................. 67 
Procedure.............................................................................................................................. 69 
Results .................................................................................................................................. 71 
Discussion ............................................................................................................................ 75 
References ............................................................................................................................ 79 
Executive summary/ dissemination document for main research paper .............................. 85 
Connecting narrative ............................................................................................................ 89 
 5 
Acknowledgements .............................................................................................................. 96 
Appendices ........................................................................................................................... 97 
(A) Appendices for Literature Review ................................................................................. 97 
Appendix A1. Instructions for authors ................................................................................. 97 
(B) Appendices for Service Improvement Project ............................................................... 98 
Appendix B1. Instructions for authors ................................................................................. 98 
Appendix B2. Measures used ............................................................................................. 100 
Appendix B3. Information relevant to ethical review ........................................................ 108 
(C) Appendices for Main research project ......................................................................... 108 
Appendix C1. Instructions for authors ............................................................................... 108 
Appendix C2. Measures used ............................................................................................. 111 
Appendix C3 Information sheet ......................................................................................... 122 



















Critical review of the literature paper 
 
Title of report:  The role of schemas in psychosis: a narrative review. 
Author:   Ania Grozdziej 
Contact details:  Department of Clinical Psychology, 6 West 0.9 
    University of Bath 
    BA2 7AY 
Email: ania.grozdziej@nhs.net 
 
Word count:   5747 
Date of report:  March 2015 
Internal supervisor:  Lorna Hogg 

















Background: Schemas or core beliefs are frequently targeted in psychological approaches 
to psychosis. However, their precise role in the formation and maintenance of psychosis is 
unclear. Schema theory can shed a new light on our understanding and clinical approaches 
to psychosis. Therefore, this article reviews the existing research on the impact of schemas 
in psychosis and discusses it in relation to theory development and clinical practice.  
 
Methods: A literature search was performed to identify studies investigating the role of 
schemas in psychosis. Articles were identified through a literature search in Embase, 
MEDLINE and Science Direct. Electronic databases were searched from inception until 
October 2014. A broad concept of schemas was used to identify as many relevant articles 
as possible. Studies investigating a concept of self-esteem were excluded. 
 
Results: The literature search identified 753 studies of which 23 met the inclusion criteria. 
The reviewed studies found significant associations between negative self and other 
schemas and positive symptoms of psychosis in both clinical and sub-clinical samples. 
Negative schemas were found to be linked to trauma or adverse life events, and 
significantly predicted the overall variance in psychotic delusions. 
 
Conclusions: This review highlights the importance of focusing on schemas and points to 
the potential role of negative self and other schemas in the development and maintenance 
of psychosis. The results suggest that schema theory can offer a valuable contribution to 
our understanding of psychosis, and has the potential to inform future research and 
treatment of psychosis. Limitations of the present research are discussed. Clinical and 
theoretical implications of findings are outlined, and possible directions for future research 
are suggested.  
 








Key practitioner messages: 
 
 Clinicians should be aware of the role of negative self and other schemas in the 
emergence of psychotic symptoms in people with psychosis, as well as those with 
prodromal symptoms, or those at risk of relapse. 
 Clinicians should consider assessing and working with schemas during therapy, in 
particular with those at risk of developing psychosis or relapsing, and publishing 
such cases to contribute to evidence based and empirical understanding of the role 
of schemas in emergence of psychosis.  
 Future research should focus on developing and testing treatment models for 
psychosis, based on its underlying psychopathology related to schemas and trauma. 
Introduction  
Psychosis is a severe mental health condition associated with complex comorbidity, 
increased risk of suicide, reduced quality of life, and poor treatment outcomes (Hawton, 
Sutton, Haw, Sinclar, & Deeks, 2005). Moreover, research suggests that childhood 
adversity and trauma is strongly associated with increased risk of psychosis (Bendall, 
Jackson, & Hulbert, 2010; Bendall, Jackson, Hulbert, & McGorry, 2008; Janssen et al., 
2004; Read, Agar, Argyle, & Aderhold, 2003; Read, van Os, Morrison, & Ross, 2005). 
This is consistent with other reviews suggesting that childhood trauma and general social 
adversity is a risk factor not only for clinical psychiatric disorders, such as schizophrenia, 
but also for subclinical symptoms including psychotic-like experiences (Matheson, 
Shepherd, Pinchbeck, Laurens, & Carr, 2013; Varese et al., 2012; Wicks, Hjern, Gunnell, 
Lewis, & Dalman, 2005). Furthermore, traumatic experiences were found to be related to 
negative schemas (Gracie et al., 2007). Despite these findings, there is limited research 
investigating treatment of psychosis in the context of the wider impact of trauma or 
negative life events, and its interplay with schemas. This means that the needs of people 
with psychosis may not be met by way of specialised treatment that would focus on 
schemas and trauma in psychosis.   
 
However, schema theory, proposed by Young (1990), may help to conceptualise the 
relationship between adverse life events, schemas and psychosis. Young et al. (2003) 
defined schemas as “broad, pervasive themes or patterns comprised of memories, 
emotions, cognitions and bodily sensations regarding oneself and one’s relationships with 
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others, developed during childhood or adolescence, elaborated throughout one’s lifetime, 
and dysfunctional to a significant degree” (p.7). This definition shares similarities with 
Beck’s  (1967) early conceptualization of schemas or core beliefs.  
 
Beck (1967) referred in his early writing to schemas, and defined them as relatively stable 
cognitive patterns, which provide basis for screening and information processing, and 
behaviours. According to Beck, individuals with a history of loss or adversity in childhood 
contribute to the formation of negative self or other schemas, containing dysfunctional 
attitudes. Dysfunctional attitudes, frequently assessed with the Dysfunctional Attitude 
Scale (DAS; Weissman & Beck, 1978) is often used to examine negative schemas or core 
beliefs, including beliefs related to success, failure, being in control, or people’s approval 
(Beck 1967; Wang, Halvorsen, Eisemann and Waterloo, 2010). Theoretically, core beliefs 
and schemas are similar and represent deeper cognitive structures or patterns than 
automatic thoughts. Young (1990) however, has elaborated on the schema concept to 
emphasise the adverse relational experiences in childhood, and described schemas as the 
deepest level of cognitive structures. 
 
According to Young et al., (2003) there are 18 EMS that schemas are present in every 
individual but are manifested in more rigid and extreme ways in people with mental health 
difficulties (Young et al., 2003). According to this model, schemas commonly develop 
during childhood in response to early trauma or adverse life events, such as abuse, neglect 
or criticisms (Young et al., 2003). Schemas can be grouped into five domains: (1) 
disconnection and rejection, (2) impaired autonomy and performance, (3) impaired limits, 
(4) other directedness, and (5) over vigilance and inhibition (Young et al., 2003). The full 
list of EMSs and schema domains are presented in Table 1. 
 
Table 1. The Early Maladaptive Schemas (EMSs) and domains (Young et al., 2003) 
 
Domains Early Maladaptive schemas 
1. Disconnection and rejection – the lack 







2. Impaired autonomy and performance – 




children, feelings undermined and 
incompetent, dependent on others 
Vulnerability to harm 
Enmeshment 
 
3. Impaired limits – limited expression of 
valid needs and emotions, difficulty 




Self control/Self discipline 
4. Other directedness – experienced 
conditional love, put the needs and 
wishes of others before their own 
Self-sacrifice 
Subjugation 
Approval seeking/Recognition seeking 
5. Over vigilance and inhibition – strict 








Over recent years, schema therapy (ST) has become increasingly popular with clinicians 
and researchers. The growing success of ST with personality disorders has raised the hope 
that ST may be useful for other complex, chronic mental health disorders, such as bipolar 
disorder or psychosis (Hawke & Provencher, 2012; Hawke, Provencher, & Arntz, 2011; 
Hawke, Provencher, & Parikh, 2013). It has been suggested that schema therapy could be 
relevant for people with severe and complex mental health difficulties, such as psychosis 
due to the high prevalence of early adversity and trauma and the role of environmental 
factors in severe mental health conditions (Birchwood, 2003; Garety, Kuipers, Fowler, 
Freeman, & Bebbington, 2001; Hawke et al., 2013). Since EMSs are considered to be the 
product of a difficult early environment (Young et al., 2003) and childhood adversity is 
high in psychosis (Bendall et al., 2010; Bendall et al., 2008; Matheson et al., 2013), 
schemas might play an important role in the development of psychosis. Given the 
complexity of psychosis and its associations with adverse life events, schema therapy has 
the potential to offer new insight into the development and treatment of this condition.  
Existing theories of psychosis also emphasise that schemas may play a crucial role in the 
emergence and maintenance of psychotic symptoms. Read et al. (2005) suggested that 
repetitive exposure to trauma and adverse life events can have a major impact on an 
individual’s core beliefs or schemas, and their emotional and behavioural responses to 
subsequent life events. These factors, combined with hypersensitivity to stress that is often 
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observed in people with psychosis, increase the likelihood of developing psychotic 
symptoms (Garety et al., 2001; Larkin, 2006; Matheson et al., 2013; Read et al., 2005).  
 
Taken together, these conceptualisations of psychosis emphasise the potential relationship 
between life events, early maladaptive schemas and psychosis. After initial focus of 
research on self-esteem and psychosis (Kesting & Lincoln, 2013; Tiernan, Tracey, & 
Shannon, 2014), the field is now beginning to recognise the importance of self-concept and 
specific schemas in the development and maintenance of psychosis. This has led to an 
increased research interest in the role of schemas in psychosis, resulting in a number of 
new empirical and theoretical studies related to this issue. Therefore, it is now timely to 
systematically review studies that have investigated the associations between schemas and 
psychosis. This paper aims to evaluate research into the role of schemas in psychosis in 
order to provide an overview of the main findings in this area, and discuss it in relation to 
existing theories and future research development. This can contribute to a better 
understanding of factors involved in the emergence of psychotic symptoms, which in turn 
can enable us to develop more effective psychological interventions for those who suffer 
from this condition. 
Methods 
 
Search strategy and selection criteria 
A literature search was performed to identify studies that investigated the role of schemas 
in psychosis. Articles were identified through a literature search in Embase, MEDLINE 
and Science Direct. Electronic databases were searched from inception until October 2014. 
The included studies investigated schemas in individuals with psychosis, those at clinical 
risk of developing psychosis, and the general population.  The main search terms included 
psychosis and early maladaptive schemas or schemas as defined by Young (1990). A broad 
concept of schemas was used in order to identify as many relevant articles as possible. This 
included studies that assessed self or other schemas, core beliefs or dysfunctional attitudes. 
Combinations of the following keywords were used: schema*, schema therapy, core 
beliefs, in combination with the following disorders from the Diagnostic and Statistical 
Manual of Mental Disorders DSM-IV-TR (American Psychiatric Association, 2000): 
Psychosis, Schizophrenia, Schizoaffective disorder, Delusional disorder, Brief psychotic 
disorder, Substance-induced psychotic disorder, and Psychotic depression. Searches were 
adapted for the different databases with Boolean operators ‘AND’ and ‘OR’ to ensure the 
most effective searches, and were performed systematically in all databases. The reference 
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lists of included studies were searched in order to identify additional studies and 
unpublished research. Finally, researchers in the field were contacted to enquire about 
ongoing research or unpublished data. 
 
Inclusion and exclusion criteria  
The inclusion criteria were: research articles published in English until October 2014, the 
study comprised of adults diagnosed with psychosis, general population and those at risk of 
psychosis. Because of the limited number of studies in this area, all research designs were 
considered including: randomized controlled trials (RCTs), controlled, uncontrolled trials, 
experimental, cross-sectional, prospective and longitudinal studies, as well as single case 
reports. Excluded from the review were studies investigating schemas in borderline 
personality disorder, bipolar disorder, theoretical reviews, and studies focusing on the 
concept of self-esteem in psychosis. 
 
Study selection  
A review of the literature was performed as recommended in the Prisma Statement (Moher 
et al., 2009). The electronic search yielded 753 articles. Two additional unpublished 
records have been identified through additional Internet searches.  Following removal of 
duplicates 188 studies were screened for the inclusion in the review. All titles and abstracts 
were initially screened and irrelevant studies or purely theoretical papers were excluded. 
Out of 188 studies, 112 were removed on the basis of title and keywords, and 49 were 
excluded on the basis of abstract. Remaining 27 studies were identified for detailed 
screening of full-text to assess further eligibility for inclusion. Out of those, 27 articles met 
the inclusion criteria for the review, and 6 were excluded. Reasons for exclusion included: 
theoretical articles or reviews (n=3), studies focusing on self-esteem or self-concept (n=2), 
studies investigating trauma and psychosis (n=1). Cross-referencing of the included 
studies, led to identification of additional 8 studies, out of which, an additional 2 met the 
inclusion criteria. Thus, the total number of articles included in the review was 23. 
The variables recorded included, (1) name of author and year of publication, (2) schema 
measure, (3) other outcome measures, (4) groups and group size, (5) main results. Quality 
assessment was not undertaken due to methodological differences in studies and the main 
focus being a narrative synthesis of the findings in this field. A flowchart of the election 
process is outlined in Figure 1. A narrative review was conducted as differences in the 
measurement and reporting of data made comparison of the main findings difficult. 
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Additional records identified 
through other sources (n = 2) 
Records after duplicates removed 
(n = 188) 
Records screened 
(n = 188) 
Studies included in 
narrative review (n =23) 
Records 
excluded by title 
and keywords (n 
= 112), by 
abstract (n = 49) 
 
Full-text articles 
assessed for eligibility 
(n = 27)  
Full-text articles 
excluded (n = 6): 
main focus on 
self-esteem  
(n = 2), trauma 
(n = 1), reviews 
(n= 3) Articles included in 
review (n = 21) 
Additional articles 
assessed from referrence 
list (n = 8), included  




Following this selection procedure, 23 studies met all the study requirements. Table 2. 
provides a summary of the included studies and outlines the main outcome measures, 
contextual information about participants and an overview of the main findings. Due to the 
heterogeneity of the included studies quality scores for each study was not included. 
 
Patient populations and group comparisons 
In total, five of the studies assessed schemas in psychosis (Fowler et al., 2006; Giblin, 
Clare, Livingston, & Howard, 2004; Siddle, Turkington, & Dudley, 1997; Smith et al., 
2006; Taylor et al., 2014), four with delusions (Bentall & Kaney, 1996; MacKinnon, 
Newman-Taylor, & Stopa, 2011; Moorhead & Turkington, 2001; Vorontsova, Garety, & 
Freeman, 2013), six explored schemas in patients with schizophrenia and other diagnosis 
(Bentall & Swarbrick, 2003; Bortolon, Capdevielle, Boulenger, Gely-Nargeot, & Raffard, 
2013; Chung, Kim, et al., 2013; Harper, 2013; Smith et al., 2006), and two studies included 
individuals who hear voices (Morland, 2006; Thomas, Farhall, & Shawyer, 2013). Two 
studies investigated schemas in first episode of psychosis (Chung, Yoon, Park, Yang, & 
Oh, 2013; Taylor et al., 2014) and one in late onset of psychosis (Giblin et al., 2004).  
In addition, four studies focused on non-clinical samples and investigated schemas in 
relation to psychotic like experiences or paranoia proneness (Fisher, Appiah-Kusi, & 
Grant, 2012; Fowler et al., 2006; Gracie et al., 2007; Oliver, O’Connor, Jose, McLachlan, 
& Peters, 2012); and four studies investigated schemas in people at high risk of developing 
psychosis (Addington & Tran, 2009; Saleem et al., 2014; Stowkowy & Addington, 2012; 
Taylor et al., 2014), 
 
With regard to group comparisons, eight studies investigated schemas among patients with 
psychosis and healthy controls (Bentall & Kaney, 1996; Bentall & Swarbrick, 2003; 
Bortolon et al., 2013; Fowler et al., 2006; Giblin et al., 2004; MacKinnon et al., 2011; 
Stowkowy & Addington, 2012; Vorontsova et al., 2013), three studies used a clinical 
comparison group of patients with depression (Bentall & Kaney, 1996; Giblin et al., 2004; 
Vorontsova et al., 2013), and one examined differences in schemas in people who 





Types of design and analysis 
Study designs included cross-sectional, longitudinal, experimental and single case study 
and analyses varied from correlational and regression analyses, ANOVA and t-tests. 
Studies of higher quality used measures of greater validity or reliability and used larger, 
more representative samples, and controlled for depression and other confounding 
variables such as age and duration of untreated psychosis. Definition of schemas varied 
considerably across studies and included early maladaptive schemas as defined by Young, 
core beliefs, and dysfunctional attitudes. A range of outcome measures were used to assess 
schemas as presented in Table 1., and three studies did not include a formal measure of 
schemas in their design (Harper, 2013; Jakes & Rhodes, 2003; Moorhead & Turkington, 
2001).
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Table 2. Summary of characteristics of the 21 studies included in the review 
Study Schema measure Other measures Groups and group size Findings 
1. Addington and 
Tran (2009) 







Scale of Prodromal Symptoms, 
the Calgary Depression Scale. 
 
 
1. Non-clinical at risk of 
psychosis (n=38) 
Results suggested that the negative self and others 
evaluations were significantly associated with 
attenuated psychotic symptoms and, in particular, 
suspiciousness. The study found no relationship 
between grandiosity and positive-self in this 
population. 






The Beck Depression Inventory 
(BDI), The Self-Referent 
Incidental Recall Task 
(SRIRT), National Adult 
Reading Test (NART). 
1. Depressed deluded 
(n=10) 
2. Non-depressed deluded 
(n=10) 
3. Depressed controls 
(n=20) 
4. Healthy controls 
(n=20) 
 
All clinical groups, individuals with depression, 
persecutory delusions, and individuals with delusions 
with comorbid depression scored highly on the DAS. 
Both healthy controls, and delusional individuals (with 
or without comorbid depression) endorsed more 
positive than negative trait words as true of 
themselves, whereas depressed individuals endorsed 
as many negative as positive trait words.  




The Need for Closure Scale 
(NCS); The Beck Depression 
Inventory (BDI). 
1. Schizophrenia (n=57) 
and delusional disorder 
(n=1).  
Out of which currently 
delusional (n=33) and 
remitted group (n=25) 
2. Control group (n=57) 
The study does not support the hypothesis that self-
schemas play a critical role in delusional disorder. 
However, it suggests that both paranoid and remitted 






4. Bortolon et al. 
(2013) 
The Young schema 
questionnaire short 
form (YSC-S). 
The Positive and Negative 
Syndrome Scale (PANSS); The 
Beck Depression Inventory-II 
(BDI-II).  
1. Schizophrenia (n=48) 
2. Control group (n=44) 
Individuals with schizophrenia scored higher than 
controls on six early maladaptive schemas (EMSs) 
after controlling for depression. EMSs were associated 
with positive but not negative symptoms. After 
controlling for depression, only Mistrust/Abuse 
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schema was a significant predictor of positive 
symptoms, accounting for 12.4% of the variance.  
5. Chung, Kim, et al. 
(2013) 
The Brief Core 
Schema Scales 
(BCSS). 
The Positive and Negative 
Syndrome Scale (PANSS); The 
Scale for the Assessment of 
Negative Symptoms, the 
Personal and Social 
Performance Scale, the Social 
Functioning Questionnaire; The 
Schizophrenia Cognition 
Rating Scale (ScoRS); The 
Basic Empathy Scale. 
1. Recovered (n=34) 





Positive self-schemas, cognitive and empathy scores 
were significantly higher in the recovered than the 
remitted group. There were no significant differences 
between recovered and remitted groups on 
demographic variables and duration of untreated 
psychosis. These results suggest positive-self schema 
and neurocognitive functioning may serve as 
important clinical characteristics distinguishing those 
who have recovered from those who have achieved 
only remission.  
6. Chung, Yoon, et 
al. (2013) 
The Brief Core 
Schema 
Scale (BCSS) 
The Ambiguous Intention 
Hostility Questionnaire 
(AIHQ), Positive and Negative 
Syndrome Scale (PANSS), and 
Psychotic Symptoms Rating 
Scales. The secondary outcome 
measures: the Scale for the 
Assessment of Negative 
Symptoms (SANS), the Social 
and Occupational Functioning 
Assessment Scale (SOFAS), 
the Toronto Alexithymia Scale 
(TAS-20), the Trait Meta-
Mood Scale (TMMS-30), the 
Beck Cognitive Insight Scale 
(BCIS), and the Scale to Assess 




episode of psychosis 
(n=24) 
 The results indicated that group CBT improved the 
clinical status of stable outpatients with first-episode 
or recent-onset psychosis.  
Following the treatment scores on negative self and 
other schemas significantly improved even though 
schemas were not specifically addressed in the 
therapeutic sessions. Psychotic symptoms were 
significantly related to the BCSS scores. Although the 
direction of causality is not certain, this study 
suggested a significant relationship between negative 











7. Fisher et al. (2012) The Brief Core 
Schema Scales 
(BCSS). 
The Childhood Trauma 
Questionnaire; The Psychosis 
Screening Questionnaire; The 
BDI; The Beck Anxiety 
Inventory (BAI) 
1. Non-clinical (n=212) This study provided initial evidence for the role of 
anxiety and negative self-schemas in the pathway 
between childhood trauma and paranoia. In particular, 
recent anxiety and negative schemas partially 
accounted for the association between physical or 
emotional abuse during childhood and paranoia. 
8. Fowler et al. 
(2006) 
The Brief Core 
Schema Scales 
(BCSS). 
Rosenberg Self-Esteem Scale, 
Depression Anxiety Stress 
Scales (DASS), Paranoia Scale 
(PA), The Peters et al. 
Delusions Inventory  
 
1. Non-clinical (n=754) 
2. Psychosis (n=252) 
The negative-other evaluations were strongly and 
uniquely associated with paranoia in the non-clinical 
sample, in combination with negative-self scores and 
anxiety. The positive-self score strongly and uniquely 
predicted grandiosity in the non-clinical sample. 
Individuals with psychosis did not differ from non-
clinical sample on self-esteem and positive evaluations 
of self and others, but showed very extreme negative 
evaluations of self and others. 




Life experiences questionnaire. 
Philadelphia Geriatric Center 
Morale Scale-Revised. 
1. Late-onset psychosis 
(n=14)  
2. Late-onset depression 
(n=13) 
3. Healthy volunteers 
(n=18) 
The late-onset psychosis group scored significantly 
higher than the control group on four out of five 
schema domains, and significantly higher than the 
late-onset depression group on two domains, other-
directedness and over-vigilance/inhibition. Both late-
onset psychosis and late-onset depression groups 
reported significantly higher levels of adverse life 
events in comparison to control group.  
10. Gracie et al. (2007) The Brief Core 
Schemas Scale 
(BCSS). 
The Traumatic Life Events 
Questionnaire; The Self-Report 
Scale-Post Traumatic Stress 
Disorder; The Paranoia Scale 
(PS); The Launay Slade 
Hallucination Scale; The 
Structured Interview for 
Assessing Perceptual 
Anomalies.  
1. Non clinical (n=228) Negative beliefs about self and others were most 
strongly associated with a predisposition to paranoia. 
The study also provided support for the link between 
trauma and psychosis mediated by negative beliefs 
about self and others. 
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Depression Anxiety Stress 
Scales (DASS), Clinical 
Outcomes Routine Evaluation 
(CORE), Qualitative outcomes 
(The client’s reflective account 
of therapy). 
1. Single case study; 
Schizoaffective disorder 
(n=1) 
Formulation driven therapy based on CBT, schema 
focused-therapy, mindfulness and compassionate mind 
training resulted in improvements in overall well-
being and depression scores. However, anxiety, stress 
and functioning scores remained above the cut-off.  




of self, others and 
what others think of 
self) 
Degree of delusional belief 
(percentage conviction); Verbal 
scale of the degree of: (1) 
preoccupation with the belief; 
(2) distress caused by the 
belief; General psychosocial 
function: (1) Inventory of 
interpersonal problems (IIP); 
(2) Social functioning scale 
(SFS); (3) Hospital anxiety and 
depression scale (HADS); (4) 
Symptom questionnaire (SQ). 
1. Case series A-B-C-D 
design; Individuals with 
psychosis and delusions 
(n=5).  
The treatment components were administered 
sequentially and included (1) Solution-focused 
Therapy (2) Schema-focused cognitive therapy (3) 
Cognitive therapy focused on modification of the 
delusion. Two clients showed reduction in degree of 
belief in their delusion during solution-focused 
therapy, one client improved during cognitive 
challenging of the delusion and one client changed 
during baseline. Negative beliefs about the self and 
other improved in all clients.  
13. MacKinnon et al. 
(2011) 
The Brief Core 
Schema Scales 
(BCSS). 
The Implicit Association Test 
(IAT); Rosenberg Self-Esteem 
Scale; The Social Interaction 
Anxiety Scale (SIAS); The 
Depression Anxiety Stress 
Scale-21 (DASS-21). 
1. Persecutory delusions 
(n=16) 
2. Healthy controls 
(n=20) 
Individuals with persecutory delusions reported 
significantly higher negative self and other schemas as 
compared to healthy control group. However, they 
showed positive implicit self-esteem, as compared to 
control group. Explicit self-esteem was lower in the 
persecutory delusion group, and was related to higher 
levels of depression and anxiety in clinical sample.  






The Maudsley Assessment of 




1. Single case study (n=1) 
delusional disorder 
The study found similarity among the schemas, the 
triggering event, and the psychotic content. Beliefs 
that mediate the relationship between main schemas 
and delusional beliefs may form a helpful focus for 
early therapeutic work in psychosis. 
 
 20 
15. Morland (2006) Young’s Schema 
Questionnaire (SQ).  
 
The Revised Edition of the 
Belief About Voices 
Questionnaire. 
1. Range of diagnosis; all 
hearing voices (n=51) 
The study indicated significant relationship between 
early maladaptive schemas (EMSs) and the belief 
people hold about their voices. Malevolence and 
Omnipotence were positively associated with several 
EMSs and Benevolence showed negative correlations.  
This suggested that beliefs about voices may reflect 
the wider beliefs people hold about themselves and 
social context.  
 




Delusional Ideation: The Peters 
et al. Delusion Inventory (PDI); 
Negative Schemas: Depression, 
Anxiety and Stress Scale 
(DASS), Psychological 
flexibility: Acceptance and 
Action Questionnaire II 
(AAQ). 
1. Non-clinical sample 
(n=700) at Time 1 
2. Non-clinical (n=204) at 
Time 2 (6 months later) 
 
Negative schemas significantly predicted higher rates 
of delusional thinking in non-clinical sample. The 
relationship between negative schemas and delusional 
thinking was partially mediated through anxiety. This 
indirect effect was moderated by psychological 
flexibility. Negative schemas significantly predicted 
higher rates of delusional thinking 6 months later, and 
this effect was fully mediated through anxiety. 
17. Saleem et al. 
(2014) 
The Brief Core 
Schema Scale 
(BCSS) 
The Structured Interview for 
Prodromal Syndromes (SIPS) 
and the Scale for Assessment 
of Prodromal Symptoms 
(SOPS), Perceived 
Discrimination measure. 
1. Clinical high risk of 
psychosis (n=360) 
2. Non-clinical (n=180) 
People at clinical high risk for developing psychosis 
endorsed a higher level of perceived discrimination, 
which is associated with increased negative schemas 
but not attenuated positive symptoms. 








1. Single case study (n=1) 
psychosis 
The study describes formulation driven treatment of 
psychosis, based on schema-focused interventions. 
The results indicated significant improvement is 
overall psychopathology symptoms, including a 
substantial reduction in schizophrenia and depression 
subscales, and improvements in social functioning. 




Scale for the Assessment of 
Positive Symptoms (SAPS); 
Positive and Negative 




delusional disorder) with 
Higher depression, lower self-esteem and more 
negative self and others schemas were related to 
higher severity of persecutory delusions and more pre-




Psychotic Symptom Rating 
Scales; Beck Depression 
Inventory-II; Rosenberg Self-
esteem Scale (RSES). 
a recent relapse (n=100)  delusions were positively associated with higher self-
esteem, lower depression, less negative self-
evaluations.  
20. Stowkowy and 
Addington (2012) 





The Structured Interview for 
Prodromal Symptoms (SIPS) 
and the Scale for Assessment 
of Prodromal Symptoms 
(SOPS); The Calgary 
Depression Scale; The Social 
Defeat Scale. 
1. Non-clinical at high 
risk for psychosis (n=38) 
2. Healthy controls 
(n=23) 
The results showed higher levels of social defeat and 
negative self and others schemas in people at risk of 
psychosis. Negative schemas mediated the relationship 
between social defeat and early symptoms of 
psychosis. This study provides preliminary support for 
the notion that maladaptive schemas play a role in in 
the onset of psychosis. 





Assessment for At Risk Mental 
States (CAARMS). 
1. First episode of 
psychosis (n=20) 
2. At risk mental state 
(n=113) 
3. Help-seeking clinical 
group with no history of 
psychosis (n=28) 
4. Non-help seeking 
individuals with some 
psychotic like 
experiences (n=30). 
The clinical groups scored significantly higher than 
the non-help seeking group on both negative beliefs 
about self and others. There were no significant 
differences between groups on positive other schemas. 
The non-help seeking group showed significantly 
higher scores on positive self-schemas then the clinical 
groups. Negative self and others schematic beliefs 
were associated with positive symptoms of psychosis 
and distress associated with those symptoms. 
22. Thomas et al. 
(2013) 




Psychotic Symptom Rating 
Scales Auditory Hallucinations 
Subscale (PSYRATS); 
Interpretation of Voices 
Inventory (IVI); Revised 
Beliefs About Voices 
Questionnaire (BAVQ-R; The 
Positive and Negative 
Syndrome Scales (PANSS). 
1. Schizophrenia or 
schizoaffective disorder – 
hearing voices (n=34) 
Negative schemas were significantly related to 
negative beliefs about voices and negative voice 
content among people hearing voices. After 
controlling for negative voice content, schemas 
predicted between 9% and 35% of variance in the six 
beliefs about voices that were measured. Negative-self 









The Brief Core 
Schemas Scale 
(BCSS) 
The Schedules for Clinical 
Assessment in Neuropsychiatry 
(SCAN); The Psychotic 
SYmptom RATing Scales: 
Delusions scale (PSYRATS); 
The Green et al. Paranoid 
Thoughts Scale (GPTS); Beck 
Depression Inventory (BDI); 
Beck Anxiety Inventory (BAI), 
The Avoidance and Action 
Questionnaire (AAQ); The 
Ruminative Response Scale 
(RRS); The Penn State Worry 
Questionnaire (PSWQ); 
Autobiographical Memory Test 
(AMT); Means-Ends Problem-
Solving; The Wechsler Test of 
Adult Reading (WTAR); 
Verbal fluency test. 
1. Persecutory delusions 
(n=60) 
2. Depression (n=30) 
3. Healthy controls 
(n=30) 
Cognitive processes associated with depression across 
the groups were negative schematic beliefs about the 
self, experiential avoidance and rumination. The 
severity of initial depression, negative self-schemas, 
worry and problem solving difficulties predicted the 
persistence of paranoia over six months amongst 
individuals with delusions. 
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Summary of the main results regarding schemas and psychosis  
Research evidence from the reviewed studies suggest that negative self and other-schemas 
are associated with positive symptomatology in both clinical (Bortolon et al., 2013; Fowler 
et al., 2006; Giblin et al., 2004; MacKinnon et al., 2011; Smith et al., 2006; Taylor et al., 
2014; Thomas et al., 2013; Vorontsova et al., 2013) and non-clinical populations 
(Addington & Tran, 2009; Fisher et al., 2012; Gracie et al., 2007; Oliver et al., 2012; 
Stowkowy & Addington, 2012). For instance, Bortolon and colleagues (2013) found that 
early maladaptive schemas predict positive symptoms in a sample of individuals with 
schizophrenia. However, after controlling for depression the Mistrust/Abuse schema was 
the only significant predictor of positive symptoms and accounted for over 12% of the total 
variance (Bortolon et al., 2013). Similarly, other studies found that negative schemas were 
related to positive symptoms of psychosis and distress associated with those symptoms 
(Taylor et al., 2014). With regard to paranoia, the results of this review indicated that 
negative other schemas predicted the severity of paranoia or paranoia proneness both in the 
clinical sample and in the general population (Fisher et al., 2012). However, Bentall and 
Swarbrick (2003) findings did not support the notion that self-schemas play a critical role 
in the formation of delusions. Instead, they emphasised high levels of intolerance of 
uncertainty, high subjective need for order, and difficulty coping with uncertainty in 
currently paranoid and remitted paranoid individuals (Bentall & Swarbrick, 2003). 
 
Between group discrepancies - comparisons with depressed patients 
Group comparisons revealed that patients with delusions reported more positive self-
schemas as compared to patients with depression, and those who are depressed and 
deluded (Bentall & Kaney, 1996; Vorontsova et al., 2013). However, patients with 
delusions regardless of whether they were depressed or not, had more dysfunctional self-
schemas compared to healthy controls (Bentall & Kaney, 1996). Vorontsova et al. (2013) 
study indicated that depression occurs in up to 50% of people with persecutory delusions 
and the severity of initial depression, negative self-schemas, worry and deficits in problem 
solving, predicted the persistence of paranoia over six months (Vorontsova et al., 2013).  
Another study that compared people with late-onset depression to people with late-onset 
psychosis indicated that people with psychosis scored higher on two schema domains 
including other-directedness and over-vigilance/inhibition (Giblin et al., 2004). This 
provides preliminary evidence that schemas may be particularly salient for late-onset 
psychosis as opposed to late-onset depression (Giblin et al., 2004).  
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Taken together, these results suggest that patients with psychosis report significantly more 
positive self-schemas as compared to patients with depression. This is consistent with 
previous research indicating that global self-esteem is enhanced in persons with delusions, 
when compared to patients with depression (Kesting & Lincoln, 2013). However, it needs 
noting that the validity of the Giblin et al. (2004) study is limited since they used Young 
Schema questionnaire that has not been validated in older populations. Bentall and Kaney 
(1996) study employed indirect measures of schematic processes, such as Dysfunctional 
Attitudes Scale and incidental recall of adjectives that are not designed to assess specific 
self and other schemas. Given those limitations, the finding that patients with persecutory 
delusions and psychosis show more positive self-schemas than patients with depression 
can be considered preliminary.  
 
Schemas in people at risk of psychosis  
Eight studies investigated schemas in people at clinical risk of developing psychosis or 
sub-clinical levels of psychosis (Addington & Tran, 2009; Fisher et al., 2012; Fowler et al., 
2006; Gracie et al., 2007; Oliver et al., 2012; Saleem et al., 2014; Stowkowy & Addington, 
2012; Taylor et al., 2014). Research findings in this area consistently indicated that 
negative self and other schemas are significantly associated with attenuated symptoms of 
psychosis (Addington & Tran, 2009). For instance, Fowler and colleagues (2006) found 
that negative-self and other schemas as well as anxiety were strongly and uniquely 
associated with paranoia in non-clinical samples. This is consistent with another study 
indicating that negative schemas, in particular negative other schemas, uniquely predicted 
prodromal symptoms of psychosis, such as suspiciousness (Addington & Tran, 2009). 
Interestingly, Oliver et al. (2013) described the processes by which negative schemas 
promote delusional thinking in healthy individuals. They found that the negative schemas 
predicted higher rates of delusions, and the relationship between negative schemas and 
delusions was partially mediated through anxiety (Oliver et al., 2012). This effect was 
moderated by psychological flexibility (Oliver et al., 2012).  Finally, it is important to note 
that the results regarding positive self-evaluations and grandiosity were mixed. While some 
studies found that the positive-self schemas were significant predictors of grandiosity and 
were related to higher self-esteem (Fowler et al., 2006; Smith et al., 2006), others found no 
significant association between grandiosity and positive self-schemas in people at risk of 





Associations between trauma, schemas and psychosis 
Four studies investigated trauma and adverse life events, and their impact on the 
development of schemas and psychotic symptoms (Fisher et al., 2012; Giblin et al., 2004; 
Gracie et al., 2007; Stowkowy & Addington, 2012). For instance, Fisher et al. (2006) 
found initial evidence for the role of anxiety and negative self-schemas in the pathway 
between childhood maltreatment and paranoia. This finding was corroborated by Gracie et 
al. (2007) research indicating that negative schemas, and PTSD symptoms related to 
adverse life events were significantly associated with a predisposition to hallucinations and 
paranoia in the general population. The same study found that negative self and other 
schemas contributed to 29% and 32% of the variance in paranoia respectively (Gracie et 
al., 2007). Those results are in accord with the findings of the previous studies conducted 
with clinical samples (Giblin et al., 2004). Thus, research in this area seems to offer 
preliminary but consistent support for the hypothesis that maladaptive schemas can 
mediate the relationship between trauma and psychosis (Gracie et al., 2007; Stowkowy & 
Addington, 2013).  
 
Hearing voices and adverse life events 
In addition, some research studies included indicated that core schemas might also play a 
role in formation of beliefs about voices (Morland, 2006; Thomas et al., 2013). This is 
partially consistent with the finding that beliefs about voices were correlated with both 
negative voice content and schemas, and negative self-schemas were the strongest 
predictors of beliefs about voices (Thomas et al., 2013). Research also suggested that 
schemas may influence the appraisal of voice in terms of power and also voice intent (e.g. 
malevolence) (Thomas et al., 2013). Thus, it appears that negative beliefs, in particular 
negative-self schemas, are potentially important in the formation of a range of beliefs, or 
interpretation of voices. 
 
The role of schemas in relapse, remission and recovery from psychosis 
Research comparing the characteristics of people who remitted and those who recovered 
from schizophrenia indicated that positive self-schemas, higher empathy scores and better 
neurocognitive functioning were significantly higher in the recovered group than the 
remitted (Chung, Kim, et al., 2013). This is significant given that the participant in those 
two groups did not differ significantly on demographic variables or duration of untreated 
psychosis (Chung, Kim, et al., 2013). Studies of individuals who recently relapsed show 
that more negative self and other schemas were related to higher levels of paranoid 
delusions, as well as being more pre-occupied and distressed by them (Smith et al., 2006). 
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Findings from case studies and group CBT for psychosis research  
Finally, three case studies and one case series described the use of different aspects of 
schema-focused work in the treatment of psychosis (Harper, 2013; Jakes & Rhodes, 2003; 
Moorhead & Turkington, 2001; Siddle et al., 1997), and one study reported findings from 
the CBT treatment for psychosis (Chung, Yoon, et al., 2013). Overall, the results were 
promising and indicated benefits to using schema work as a treatment of psychosis, with 
one study indicating improvements in negative self and other schemas following group 
treatment for psychosis (Chung, Yoon, et al., 2013). Additional outcomes reported in 
previous case studies include improvements in psychological distress and functioning and 
overall better quality of life (Harper, 2013; Moorhead & Turkington, 2001; Siddle et al., 
1997). The results of one study that used a series of single case experiments comparing a 
stable baseline with an active treatment found that solution-focused therapy was more 
effective at reducing degree of conviction in psychotic delusions, than schema focused 
work (Jakes & Rhodes, 2003). This is however, not surprising given that schema therapy in 
this study did not specifically target delusional conviction. Moreover, as the order of 
treatment was confounded in this study it is not possible to say if the solution focused 
therapy was more effective because it was the first treatment or because of its particular 
characteristic (Jakes & Rhodes, 2003). However, it is important to note that the validity of 
those results is limited due to methodological weaknesses of those studies and lack of 
formal assessment of schemas and schema change in three of the included case studies 
(Harper, 2013; Jakes & Rhodes, 2003; Moorhead & Turkington, 2001).  
Discussion 
Overall, this review indicates the importance of schemas in the development and 
maintenance of psychosis. The main findings from the included studies suggest a 
significant relationship between negative schemas and positive symptoms of psychosis. In 
particular, research demonstrated the significance of negative self and other schemas in the 
formation of positive symptoms amongst clinical and sub-clinical samples (Addington & 
Tran, 2009; Fowler et al., 2006; MacKinnon et al., 2011; Smith et al., 2006). Furthermore, 
some studies suggested that negative self-schemas were independently associated with 
delusions, even when the confounding effects of low self-esteem and depression were 
controlled for (Smith et al., 2006). Negative self-schemas were also found to be associated 
with distress related to hallucinations, and the intensity of its negative content (Smith et al., 
2006). Thus, these results seems to indicate that people with psychosis show extreme self 
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and other schemas that are related to positive symptoms of psychosis, and this effect is 
independent of the impact of mood.  
 
Interestingly, the reviewed studies indicated that people with psychosis did not differ 
significantly from healthy individuals, on measures of positive self-schemas, and reported 
more positive self-schemas than individuals with depression (Fowler et al., 2006; 
MacKinnon et al., 2011; Smith et al., 2006). Thus, it seems that positive self-schemas are 
maintained, or at least less impaired in individuals with psychosis (Fowler et al., 2006; 
Kesting & Lincoln, 2013; Smith et al., 2006). This is in contrast to non-clinical samples, 
which tend to report more positive and fewer negative self-evaluations, and to people with 
depression, who report more negative and fewer positive self-evaluations (Kesting & 
Lincoln, 2013; Tiernan et al., 2014). These findings are consistent with previous reviews 
investigating the relevance of self-esteem or self-concept in psychosis (Kesting & Lincoln, 
2013; Tiernan et al., 2014). 
 
Therefore, the notion that negative schemas are relevant in psychosis, as proposed by the 
existing theories, has preliminary support in empirical research. However, the mechanisms 
behind those associations remain unclear. The results of Smith et al. (2006) study suggest 
that there may be different association for different symptoms. For instance, they found 
that negative self-schemas were independently associated with persecutory delusions but 
not with auditory hallucinations (Smith et al., 2006).  
 
Schemas in people at high risk of psychosis and those who recovered  
Secondly, the reviewed studies indicate that schemas may be particularly relevant in 
prodromal psychosis. The reviewed studies in this domain consistently indicate that 
negative self and other schemas predicted higher levels of paranoid ideation in non-clinical 
samples, while elevated positive self-schemas predicted grandiosity (Fowler et al., 2006; 
Smith et al., 2006). Furthermore, Chung et al. (2013) showed that positive self-schemas 
might be important clinical characteristic distinguishing those who recovered compared to 
those who achieved remission (Chung, Kim, et al., 2013; Smith et al., 2006). However, the 
validity of these findings are restricted by the use of non-clinical samples and cross-
sectional design. Therefore, further research his warranted to corroborate these findings 





Trauma and psychosis 
Finally, there is preliminary evidence indicating the role of negative self-schemas in the 
pathway between childhood trauma and psychosis (Fisher et al., 2012). This proposal is 
corroborated by evidence that negative schemas were significantly associated with 
predisposition to paranoia (Giblin et al., 2004; Gracie et al., 2007). However, it is 
noteworthy that these results are based mostly on retrospective, cross-sectional research 
with non-clinical samples. Therefore, further research is warranted to establish the validity 
and generalizability of these findings. Nevertheless, these results are of interest, and are 
consistent with the current theories indicating the potential role of schemas in the 
development and maintenance of psychotic symptoms (Birchwood, 2003; Garety et al., 
2001).  
 
Theoretical overview and conceptualization of the potential role of schemas in psychosis 
In order to provide an explanation of how schemas can impact and interact with positive 
symptoms of psychosis, it is important to integrate current models of psychosis with the 
research evidence in this area. Firstly, it is important to note that previous research points 
to a significant link between adverse life events and interpersonal stressors, and an 
increased risk of developing psychosis (Matheson et al., 2013; Read et al., 2005) and early 
maladaptive schemas (Young, 1990). This is of particular interest since negative self and 
other evaluations have been incorporated into different models of paranoia and persecutory 
delusions (Bentall, Corcoran, Howard, Blackwood, & Kinderman, 2001; Bentall & 
Swarbrick, 2003; Birchwood, 2003; Garety et al., 2001). More specifically, Garety et al. 
(2001) proposed that early traumatic experiences could contribute to the formation of 
negative schemas, which in turn can have an impact on delusional beliefs and emotional 
distress. These theories are consistent with evidence for the role of negative schemas, 
anxiety (Fisher et al., 2012) and depression (Garety et al., 2001) in the pathway between 
childhood maltreatment and psychosis. They are also consistent with research indicating 
that schematic beliefs mediate the relationship between lifetime trauma and paranoia in the 
general population (Gracie et al., 2007).  
 
In line with these findings, it is therefore possible that early maladaptive schemas become 
reactivated in response to stress and difficulties with social relationships in a vulnerable 
person (Bortolon et al., 2013; Fisher et al., 2012). These reactivated schemas can then lead 
to increased levels of stress and anxiety which can have a negative effect on information 
processing and cognitive biases, including jumping to conclusions (Freeman, Garety, 
Kuipers, Fowler, & Bebbington, 2002). These responses can be exacerbated by the deficits 
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in emotion regulation and vulnerability to stress (Freeman et al., 2002; Garety et al., 2001; 
Read et al., 2005). Taken together, all those factors can contribute to increased anxiety and 
paranoid misinterpretations of ambiguous situations, in a vulnerable person predisposed to 
developing psychosis (Freeman et al., 2002; Garety et al., 2001). Psychotic symptoms 
could therefore be explained to emerge as a function of reactivated schemas, in the context 
of previous trauma or adverse life events, deficits in effective emotion regulation, and 
maladaptive cognitive and emotional responses to stress (Birchwood, 2003; Freeman et al., 
2002; Garety et al., 2001; Morrison, Frame, & Larkin, 2003). The experience of psychosis 
can then lead to social withdrawal, shame and stigma, which in turn can increase distress, 
and confirm negative self and other beliefs thus maintaining the vicious cycle. 
 
Existing theories of psychosis, considered in this paper, explain the relationship between 
adverse life events and schemas, and provide us with a valuable knowledge upon which to 
base further research into the role of schemas in psychosis. However, future research in 
this area should move away from correlational design, towards more experimental, 
longitudinal, and treatment studies, to test those theories, and provide new implications for 
clinical practice. Linked to this, it is striking that this review revealed a significant number 
of articles investigating the relationship between schemas, trauma and psychosis, but a 
comparatively small number of treatment studies that would address schemas in people 
with psychosis. Furthermore, research and theories seem to indicate that previous trauma 
or adverse life events are likely to be prominent features in many people struggling with 
psychosis. However, the sparse treatment studies discussed in this review did not tailor 
their treatment to directly explore schemas and trauma, which may contribute to the 
development and maintenance of psychosis. Instead, schemas in the context of previous 
trauma and psychosis seem to be almost ignored in the treatment literature to date. 
 
Limitations 
It is important to note some limitations of the present review. The majority of the studies 
included in this review have used cross-sectional design to investigate the role of schemas 
in psychosis. This precludes conclusions regarding causality, and does not clarify whether 
negative schemas are the cause or the consequence of psychosis (Smith et al., 2006). 
Therefore, as already mentioned more experimental or longitudinal research is warranted 
to further investigate the stability or change of schemas over time, and its impact on 
psychosis. The generalizability of the present findings is limited by the use of highly 
heterogeneous, self-selecting and non-clinical samples that may not be fully representative 
of people with psychosis.  
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Additional methodological limitation in this field of research relates to the use of different 
definitions and measurement of schemas (i.e. schemas, core beliefs, dysfunctional 
attitudes). It would therefore be of value for future research to investigate the conceptual 
overlap between EMS, core beliefs and dysfunctional attitudes in order to establish 
whether these separate definitions are indeed necessary and appropriate. Future research 
trials would benefit from the use of clear, and consistent operational definition of schemas, 
and its measurement. A further limitation of the present study is that it included only 
studies published in English and may be confounded by the publication bias. 
 
Clinical and research implications 
The findings of the present review have a number of implications for theory, clinical 
practice and future research. First of all, further research is needed to prove the utility of 
schema theory in improving our understanding of the development, maintenance and 
treatment of psychosis. Inclusion of a control clinical group would be a valuable addition 
to the field, in order to evaluate patterns of schemas across different clinical groups. 
Furthermore, future studies in this area should aim to include larger sample sizes and 
greater consistency in methodology. In particular, a clear operational definition of 
schemas, and use of validated schema measures, such as The Brief Core Schema Scale 
(Fowler et al., 2006) would be beneficial, as mentioned above. This would improve the 
quality of research and facilitate comparison of findings across different studies. Future 
research would also benefit from longitudinal research to evaluate the stability or change 
of schemas across time, and its impact on psychotic symptoms. Finally, it could be 
interesting for future studies to explore whether fluctuations in negative and positive 
schemas could be used as a clinical indicator of early signs of relapse. 
 
In terms of clinical applications, the present study indicates that schema theory may offer a 
promising way of conceptualising the development of psychosis. Greater understanding of 
the pathways between schemas and psychosis, and the role of trauma in this process, could 
contribute to the development of preventative or therapeutic interventions for people with 
psychosis, or those at clinical high risk for psychosis (Fisher et al., 2012; Smith et al., 
2006). Although schema therapy in its original form has not been indicated for individuals 
with active psychosis (Young, 2003), clinicians could adapt their formulations and apply 
schema-based interventions to their work. This is particularly important in the light of the 
scarcity of treatment literature in this area. More research could bring new insight into 
treatment of psychosis, and allow comparison of the effectiveness of schema-focused 




This study presents the results of a literature search pertaining to the role of schemas in 
psychosis, and provides preliminary support for the notion that schemas play an important 
role in the emergence and maintenance of psychotic symptoms. An improved 
understanding of the specific mechanism involved in the development of schemas and 
psychosis could lead to better prevention or management of this condition. This provides a 
rationale to continue expanding research in this area, and develop new therapeutic 
interventions to support people who suffer from psychosis.  
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This paper reports on an evaluation of a pilot implementation of a Systems Training for 
Emotional Predictability and Problem Solving (STEPPS) programme delivered within a 
secondary care service in the UK. The paper will present a brief review of the relevant 
literature regarding the development and evaluation of the STEPPS programme, followed 
by the results of a pilot study of the effectiveness of the STEPPS intervention and client’s 
satisfaction with services within the UK secondary care setting. Although the participants 
found the programme acceptable, there was little evidence for its effectiveness. 
Recommendations for clinical practice and further research are presented.  
Introduction 
 
Borderline personality disorder (BPD) is characterised by significant instability of 
interpersonal relationships, self-image and mood, fear of abandonment and rejection (Levy 
et al., 2006). This is often accompanied by a strong tendency towards impulsive behaviour, 
suicidal thinking and self-harm (APA, 1994). Research suggests that BPD is occurs in 
approximately 1–4% of the general population, 10–15% of psychiatric outpatient 
population, and up to 20% of psychiatric inpatients (Lenzenweger, Loranger, Korfine, & 
Neff, 1997; Torgersen, Kringlen, & Cramer, 2001; Widiger & Weissman, 1991; 
Zimmerman, Rothschild, & Chelminski, 2005). There is also evidence that BPD is often 
associated with poorer quality of life, co-morbid mental health conditions such as 
depression and anxiety, and excessive use of the health care system (Blum et al., 2002).  
 
The National Institute for Health and Clinical Excellence (NICE) currently recommends 
several evidence-based treatments for the management of BPD (NICE, 2009). These 
include Dialectical-Behaviour Therapy (Linehan, 1993; Linehan, Armstrong, Suarez, 
Allmon, & Heard, 1991; Linehan et al., 2006), Cognitive-Behavioural Therapy (CBT) 
(Davidson et al., 2006), Schema-Focused Therapy (Giesen-Bloo et al., 2006), and 
Mentalization-Based Therapy (Bateman & Fonagy, 2010). Despite an increasing body of 
research evaluating the outcomes of these psychological treatment approaches, NICE 
suggested that the evidence for these treatment models is not conclusive (NICE, 2009). 
Unfortunately, all of these approaches are costly and involve long-term treatment plans. 
Hence, recent efforts have focused on developing a model of treatment for BPD that is 
cost-effective and efficient in reducing psychological distress, self-harm as well as 
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inpatient admissions associated with BPD. One of the most promising of these is the 
Systems Training for Emotional Predictability and Problem Solving programme (STEPPS) 
(Blum, Pfohl, St John, Monahan, & Black, 2002).  
 
STEPPS is a programme that employs aspects of CBT, alongside a systemic component, 
recognising the importance of support from a person’s family and friends. It was adapted 
from a twelve-week psycho-educational programme developed by Bartels and Crotty 
(1992). It was then extended to a twenty-week programme with specific facilitator 
guidelines and agendas for each week of the treatment (Black, Blum, & St. John, 2009; 
Blum et al., 2009). The STEPPS treatment is divided into two distinct but overlapping 
parts, with the first twelve sessions focusing predominantly on psycho-education about 
BPD, emotional management skills and development of adaptive coping strategies. The 
remaining eight sessions focus on behaviour management skills, including goal-setting, 
interpersonal relationship management, abuse, avoidance, sleep hygiene and nutrition, 
exercise and physical health (Black, Blum, & St. John, 2009). There is a growing evidence 
base for the effectiveness of the STEPPS programme, with a number of uncontrolled trials 
reporting significant improvements in mood and functioning, and reductions in the degree 
of impairment associated with BPD (Black et al., 2009; Blum et al., 2002; Stoffers et al., 
2012). Perhaps most importantly, a Randomized Controlled Trial (RCT) comparing 
STEPPS plus treatment as usual, to treatment as usual alone found that STEPPS led to 
significant improvements in functioning, depression and BPD related symptoms and 
behaviours (Blum & Black, 2008). In particular, it has been shown that the STEPPS 
programme has been associated with a reduction in impulsive behaviours, self-harm, and 
symptoms of depression and anxiety (Blum et al., 2008; Black et al., 2009). Blum et al., 
(2002) stated that in their experience, most patients will have benefited from STEPPS, and 
will report improvement in their symptoms, and control over impulsivity and self-harm 
behaviours (Blum et al., 2002). However, many may need a longer follow-up in order to 
internalize the lessons and practice their skills (Blum et al., 2002). Therefore, Blum et al., 
(2002) recommended a one-year, twice monthly extension programme called 
STAIRWAYS (an acrym for Setting goals; Trusting and taking risks, Anger management, 
Impulsivity control, Relationship behaviour, Writing a script, Assertiveness training, Your 
journey, and Schemas revisited). The main focus of STAIRWAYS is to maintain the skills 
learned in STEPPS, whilst providing a lower intensity of service (Blum et al., 2002).  
 
According to the World Health Organisation (WHO, 2000), attempts to evaluate client’s 
satisfaction is an excellent opportunity to involve patients in the process of evaluating 
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services (WHO, 2000).  Pisarski (2011) and colleagues suggested that careful 
consideration of client’s satisfaction with services could enhance the process of redesign of 
services and lead to more effective and acceptable care. This suggests that investigation of 
client’s views and perceptions of their treatment should be a crucial aspect of service 
evaluation. Other research suggests that clients’ perceptions of their treatment can have a 
major impact on their adherence, and subsequent treatment outcomes (Ruggeri, 1994). This 
is of particular importance for individuals with BPD who are at higher risk of premature 
discontinuation of treatment (Black et al., 2009). Therefore, evaluation of client’s 
satisfaction could potentially help to identify factors associated with an increased risk of 
drop out from services. This in turn could enable service providers to address those issues 
more effectively, although it is important to note that research on the relationship between 
client’s satisfaction and outcomes in mental health services have been limited and 
somehow inconsistent (Turchik et al., 2010; Garland, Haine and Boxmeyer, 2007; Hasler 
et al., 2004).  
 
There is yet to be an evaluation of clients’ satisfaction with the STEPPS programme 
delivered within the UK secondary care services. This brings us into the aims and scoping 
of this project. 
 
Scoping of the project 
 
Consultation with the Psychological Therapies Service (PTS) in South West England 
revealed that the support offered to clients referred with BPD features was not sufficient in 
meeting the needs of this group. Consequently, the service providers proposed setting up a 
pilot STEPPS group that would constitute an additional treatment choice for people with 
BPD. Subsequent consultation within the team focused on establishing the most 
appropriate set up of the group, and outcomes measures that would be used to evaluate 
outcomes of this programme. In collaboration with the service, it was agreed that data from 
the STEPPS programme would be used to offer recommendations for service 
improvement, with the aims of improving therapy offered to people with BPD.  
 
The main aims of this study were to evaluate: (1) the outcomes of a pilot Systems Training 
for Emotional Predictability and Problem Solving (STEPPS), and (2) based on the previous 
literature to evaluate client’s satisfaction with their treatment and overall service provision, 





The present evaluation used a mixed method design. More specifically, it employed a 
combination of quantitative methodology (i.e. evaluation of the pre and post-treatment 
outcomes), alongside the evaluation of qualitative feedback from participants regarding 
satisfaction with their treatment and service concerned.  
 
Approach 
Analyses were performed using SPSS 22 (SPSS Inc. IBM, Chicago, Illinois, USA), with 
statistical significance set at p<0.05. In addition, thematic analysis was applied as a method 
of analyzing qualitative data from surveys. This approach allowed for identification of 
emergent themes not explicitly stated in survey questions (Braun & Clarke, 2006). It also 
enabled more in-depth analysis of participants’ personal experiences of the STEPPS 
programme and their satisfaction with the overall service. According to Braun and Clarke 
(2006), a thematic analysis involves a series of phases that allow for exploration of 
personal meaning for participants, whilst maintaining the flexibility associated with this 
epistemological position. The theoretical framework is based on organizing key issues 
emerging from data, and grouping them into themes reflecting important aspects of 
personal experiences attached to a particular subject in question (Braun & Clarke, 2006).  
 
Participants 
Fourteen people were referred to the psychological therapy service to take part in the 
STEPPS programme, by their respective community mental health team care coordinators. 
Subsequently, twelve participants were invited to a pre-group assessment session, and of 
those nine attended the STEPPS programme (N=9). The reasons for not choosing STEPPS, 
included a preference to undertake an alternative therapy namely Dialectical Behaviour 
Therapy (DBT) (N=1), time commitments (N=1), anxiety about attending group (N=1), 
and other reasons not specified (N=2). All participants were females, and had the mean age 
of 34, (range 19 to 70); eight participants were white British, one was mixed-race.  
 
Measures 
The following measures were used to evaluate the STEPPS group and service user’s 
satisfaction with the service provision: 
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The Borderline Evaluation of Severity Over Time (BEST) is a self-report questionnaire 
designed by Pfohl et al. (2009) to assess the degree of impairment or interference from 
each of the nine BPD criteria over the past week (Pfohl et al., 2009). It is rated on a five-
point scale, with scores ranging from 12 to 72, with the higher scores indicating higher 
levels of severity. The BEST scale has moderate test-retest reliability, high internal 
consistency, and high discriminate validity (Pfohl et al., 2009).  
 
The Clinical Outcomes in Routine Evaluation – Outcome Measure (CORE–OM) is a self-
report measure that is widely used to assess outcomes from psychological therapy 
(Barkham et al, 2001; Evans et al, 2002). The CORE–OM comprises 34 items addressing 
domains of subjective well-being, symptoms, functioning, and risk. Items are scored on a 
five-point scale ranging from 0 (‘not at all’) to 4 (‘all the time’). The total score can range 
from 0 to 140, with a cut-off point of 20 for healthy sample, 21-33 low levels of distress, 
34-50 mild, 51-67 moderate, 68-84 moderate to severe, 85+ severe. 
 
The Service User Satisfaction Survey was used to evaluate different aspects of client’s 
satisfaction with service delivery (Pisarski et al., 2011). The survey includes five sections 
measuring the (1) overall satisfaction, (2) satisfaction with information and contact with 
the clinic, (3) waiting times, (4) questionnaires, and (5) the treatment. A blank space was 
available at the end of each section to allow suggestions regarding how that specific area 
could be improved. A longer blank space was available at the end of the questionnaire for 
any further comments (Pisarski et al., 2011). The responses are rated on a five-point Likert 
scale, with one question being reverse scored. The scores can range from 0 to 75, with the 
higher scores indicating higher levels of satisfaction with the specific area (Pisarski et al., 
2011).  
 
The STEPPS Evaluation Survey was adapted by the researcher and the service from a 
questionnaire described in Blum et al. (2002). The specific adaptation included a change of 
the rating scale from a seven-point Likert scale to a five-point Likert scale, to make the 
survey more accessible, and exclusion of one question that was considered less relevant for 
the purpose of this evaluation (i.e. “My therapist did not agree with what I was taught”). 
Those changes were deemed acceptable, as the survey has no reported established 
reliability, therefore changing the structure of it would not affect its reliability. The final 
scale included 13 items, with one question being reverse coded. The total score can range 




Two facilitators ran the group and collected outcome measures. The main facilitator was a 
Chartered Clinical Psychologist, experienced in running groups. The co-facilitator was a 
Trainee Clinical Psychologist, which changed towards the end of sessions to another 
clinician. The outcome measures were collected as a routine part of the service evaluation. 
The BEST measure was administered weekly for the duration of treatment, and at 2 month 
follow-up. The CORE-OM was administered at four points: pre-treatment, half way 
through the treatment, post-treatment, and at 2 month follow-up. In addition, the 
participants were asked to complete The Service User Satisfaction Survey and the STEPPS 
Evaluation Survey after their last session of the STEPPS programme. As already 
mentioned both surveys included the multiple-choice questions alongside a series of open-
ended questions, requesting textual responses. After gathering the results, qualitative data 
from the open-ended questions was tabulated and the textual responses were collated for 
further analysis. This data was then analysed using Thematic Analysis approach (Braun & 
Clarke, 2006). The first step involved reading and re-reading the data several times in order 
to facilitate immersion and familiarity with the data set. Following on from this, the data 
was coded according to the main issues considered to be pertinent to the research question. 
The third stage involved searching for themes within the data and combining different 
codes that shared common patterns. At this stage the themes that were too diverse or did 
not have enough data to support them were discarded (Braun & Clarke, 2006). Each theme 
was then named in order to convey its essence. Finally, a selection of citations from the 
participants was chosen to provide a lucid example of the main issues identified within 
each theme (Braun & Clarke, 2006). 
 
Ethics 
The study was assessed and approved by the University of Bath Psychology Department 
Research Ethics Committee. The local NHS Research & Development (R&D) office was 
consulted regarding the need for any additional ethical approval for the study. Due to the 
fact that the data was collected as an integral part of the service evaluation, and did not 
require any additional time or activity on the part of the participants, this was regarded as a 
service evaluation project and not subject to prior ethical approval from the R&D. All 
participants gave consent to allow outcome data to be used to evaluate the effectiveness of 





The results of the descriptive statistics are summarized in Table 1. below. The Wilcoxon 
Signed-Rank test was conducted to compare changes in participants’ mean scores from pre 
to post-treatment, and follow up. The results indicated that the STEPPS programme did not 
elicit a statistically significant change in BPD symptoms from pre to post-treatment, Z= -
.356, p=0.722. Similarly, the STEPPS programme did not elicit statistically significant 
changes in the participants’ BPD symptoms from pre-treatment to 2 month follow-up, Z= -
.507, p=0.612.  
 
Table 1. Descriptive statistics for the BEST and CORE measures from pre to post-
treatment and follow-up. 
 
Measure Mean score (SD) Range 
BEST pre-treatment 45.1 (SD=9.5) 29-58 
BEST post-treatment 43.4 (SD=16.5) 23-65 
BEST 2 month follow-up 43.7 (SD=15.2) 18-66 
CORE pre-treatment 83.1 (SD=14.5) 67-110 
CORE post-treatment 76.5 (SD=28.8) 41-114 
 
Visual analysis of data was used to interpret and draw inferences from data collected 
during the study. With regard to changes in symptoms of BPD, visual inspection of data 
presented in Graph 1 revealed no clear treatment effects or trends. Although there were 















Psychological distress and functioning 
As for the changes in psychological distress and functioning, the results of the Wilcoxon 
signed-rank test indicated that the STEPPS programme did not lead to statistically 
significant improvement in participants’ global distress measured on CORE-OM from 
assessment to end of treatment, Z= -.734, p=0.463. 
 
This was consistent with the visual examination of graphed data indicating no reliable or 
consistent pattern that would indicate positive effects of the intervention for the group as a 
whole (Graph 2.). Instead, it appears that three individuals improved, two indicated slightly 
higher distress and one remained unchanged following post-therapy. Therefore, the use of 
visual inference and statistical procedures found no benefits on BPD and distress related 















Graph 2. Changes in the CORE-OM scores from pre to post-treatment for each participant 
 
 
Please note: pre and post-treatment data for participant 3 is missing; participant 7 
reported only pre-treatment scores, while participant 9 reported only post-treatment 
scores. 
 
Participants’ satisfaction with the STEPPS treatment 
Seven out of nine participants (77%) responded to the STEPPS Treatment Evaluation 
Survey. Overall, the results indicated high satisfaction with the STEPPS treatment 
(M=47.2, SD=4.8), with 60 being the maximum score. All participants reported attending 
more than half of the sessions, with the overall attendance rate of 77%. 
 
Structure 
Length of sessions 
All participants reported that the STEPPS programme was too short, and five out of the 
seven indicated that the time given to learn new skills was insufficient.  
 
Materials used in sessions 
The results indicated varying results regarding the amount of material covered in the 
STEPPS programme. More specifically, four of seven people reported that there was too 
little material used in sessions, two considered it too much, as one was satisfied with it.  
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Discussion of intense emotions 
Similar discrepancy emerged with regard to the time allocated to discussing intense 
emotions. More specifically, four people felt that there was too much time spent on 
discussing difficult emotions, one person felt it was not sufficient, another individual 
thought there was enough information, and four felt it was too much.  
 
Skills 
All participants reported that they were given a clear explanation of what BDP means, and 
they considered the manual a helpful part of their treatment. Moreover, six participants 
reported that the skills learned in therapy were highly effective and taught them how to 
handle their difficulties better. For instance, three participants reported that they have been 
much less likely to harm themselves after undertaking the STEPPS programme, however 
another three were neutral, and one person reported no difference in their self-harming 
behaviour. 
 
Satisfaction with services survey 
 
Information provision and communication with the service 
Seven out of nine participants (77%) completed The Service User Satisfaction Survey. 
Overall, the results suggested high satisfaction with the experiences of the service 
concerned (M=50.8, SD=11.8). With regard to information provision, three of out the 
seven participants reported high satisfaction with the information they were given on what 
to expect before their treatment, and the method of receiving this information (e.g. 
appointment letter, phone calls). Moreover, four participants felt that the written 
communication from the service was clear and effective. However, two participants 
reported dissatisfaction with the service received at the reception. 
 
Use of questionnaires 
As part of the routine practice and evaluation of outcomes, all participants were asked to 
fill in a number of questionnaires at various stages in their treatment. Four participants 
reported that they were given satisfactory reasons for completing the questionnaires (67%), 





Satisfaction with waiting times 
The available data on waiting times was poor and did not enable calculations of an average 
waiting time. However, the reported waiting times varied from less than a month to 6 
weeks for an assessment, and between a few weeks to 3 months for treatment. Three out of 
the seven participants were dissatisfied with their waiting times, and the information they 
received about waiting times. However, another three participants were very satisfied with 
their waiting times and information regarding this.  
 
Satisfaction with treatment 
All participants reported feeling respected and listened to by their therapists.  Four out of 
the seven participants (67%) reported that they felt involved in choices about their 
treatment, and felt that their goals and expectation at the start of the group had been met. 
Two out of the seven participants (33%) users felt that the help provided at the clinic 
allowed them to resolve their main problem.  
 
Qualitative Results  
 
Four overarching themes were identified from data: (1) Change in therapy; (2) The role of 
therapeutic alliance; (3) Ideas for improvement; (4) Therapy endings. Sub-themes were 
evident within each of the overarching themes. These will be described in turn, and 
illustrated with relevant quotations. For the purpose of confidentiality all names have been 
removed from quotations.  
 
Theme 1. Change in therapy 
One of the most prevailing themes was related to the change in therapy and ‘personal 
benefits’ of taking part in the STEPPS group. All participants saw therapy as being 
characterized by the process of talking about their difficulties with others, feeling accepted 
and understood. This overarching theme breaks down into three sub-themes: Feeling cared 
for and understood; Improved coping skills; and Personal benefits. 
 
i. Feeling cared for and understood 
All participants spoke of a sense of feeling safe, supported and understood, as one of the 
main benefits gained from therapy. This is illustrated in the following quotes: 
 
“This has been the most effective treatment I have had so far. A group environment 
has made me feel as if other people understand me”. 
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“I have never met such an incredible bunch of people. Everyone has made me feel 
so welcome”. 
 
Moreover, many participants said that they felt that they fit in and belong, which reduced 
their feelings of loneliness and feeling different.  
 
“It has been the first time in so long that I’ve found a group where I feel I fit in”. 
“Everyone is so similar but also different. I no longer feel alone or weird”. 
 
ii. Improved coping skills  
Moreover, many participants reported a number of positive changes that resulted from their 
participation in the STEPPS group. This included improvements in communication skills, 
emotions management, and reduced self-harm. 
 
“I have pondered about self-harm and have been very close to it but I have not, but 
I do feel that I can trust myself not to self-harm when I spin into crisis”.  
 
“This is the first time I feel I have been given help to help myself”.  
 
The quote above seems to capture a sense of agency and self-efficacy for managing 
personal difficulties. 
 
iii. Personal benefits 
The number of common themes emerged when participants were spoke of benefits of 
therapy. Many participants reported a number of changes including being more able to deal 
with their problems, and cope with extreme feelings and thoughts, feeling happier, and 
being less judgmental towards themselves.  
 
“I have stopped exploding and seem to keep calm. Also have stopped judging 
myself most of the time”. 
 
“I felt I had people to go to and I have been able to question unhelpful thoughts”. 
 




 “Psychosis has hugely reduced. My trauma flashbacks used to haunt me all day 
but now they don’t”. 
 
Theme 2: The role of therapeutic alliance 
A number of participants commented that they valued hard work from the group 
facilitators and appreciated their therapeutic style characterised by approachability, feeling 
safe and understood.  
 
“The facilitators enabled the group safety and support so we have been very 
positive to each other”. 
 
However, the group felt that if possible, future groups should avoid change of group 
facilitators, as this may have a detrimental effect on the cohesion and continuity of the 
group.  
“I (…) would strongly suggest that therapist do not change during the course as 
you have built up trust and then someone else comes in and could make things 
difficult. Also it is not good for the therapist as they don't get the consistency or get 
to see how much their hard work is paying off”. 
  
Theme 3: Ideas for improvement 
The third overarching theme was “Ideas for improvement” with four sub-themes as 
follows. 
 
i. More time to consolidate skills 
The majority of the people felt that the course was not long enough and did not allow for 
consolidation of new skills, as illustrated below: 
 
“This course has been extremely helpful. I’m totally positive. Any criticism would 
be that not enough was given to each skill”. 
 
“Maybe the weekly meetings could be lengthen by half an hour, so more time is 
spent on the skills and ways of implementing them, so a better understanding”. 
 
ii. Specific topic of interest 
Moreover, the participants identified a number of topics that they would like to explore in 
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more depth during the session. This included the issues around schema work and filter, 
specific skills about positive spins, problem solving, and dealing with relationships 
difficulties and abuse.  
 
iii. Involve the support system around the person 
Another sub-theme related to involvement of reinforcement team as well as the need for 
more support from care-coordinators. In particular, the service users reported that 
involving family and friends would be beneficial, and could happen more frequently and 
earlier on in their treatment.  
 
“I feel it would be beneficial for the evening session with our reinforcement teams, 
be organised for within the first 4 weeks, with date set out at the start of the group. 
As I feel I am not utilising my reinforcement team correctly, as I don’t think I fully 
understand their role”. 
 
While many participants commented on the usefulness of the support from their family and 
friends, some did not fully understand their role in treatment, and how to fully utilize this 
source of support. 
 
iv. Reduce paper work and allow more time for discussion 
The group also found the amount of paper work overwhelming, and spoke of their 
preference of having more time for discussion and taking own notes. Some participants 
also noted a detrimental effect of being overwhelmed with paperwork and how this could 
lead to sense of failure.  
 
“I felt that the level of paper work and homework could potentially put some people 
off. Some weeks had so much homework it was off putting and was a struggle to do, 
as lack of time due to just trying to survive the week. This does not help if you are 
constantly judging yourself, which could lead to a negative reaction”. 
 
Theme 5: Managing therapy endings 
The feedback also pointed out to the need for more careful consideration of discharge 
planning and therapy “endings”, as premature termination of services or support from care 
coordinators may contribute to a relapse.  
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“Do not just cut off treatment after 20 consecutive weeks, it can be very harmful 
(…). This is extremely dangerous and such a waste of time of all the hard work and 
support the psychologist gave us (…)”. 
Discussion 
 
The present study was intended to evaluate clients’ satisfaction with services and outcomes 
associated with the introduction of the STEPPS programme within the UK secondary care 
services. Of particular interest was the finding that qualitative and quantitative analysis 
appeared to yield contrasting results. More specifically, the preliminary evaluation of the 
quantitative data indicated no changes from pre to post-treatment and 2 months follow-up. 
Thus, the results of this investigation suggested that the STEPPS program did not lead to 
significant and clinically meaningful improvements in symptoms of BPD, mood and 
functioning. This is in contrast to the previous research (Blum et al., 2002; Blum et al., 
2008; Black et al., 2008). The qualitative findings from this evaluation suggested a range 
of positive outcomes for the participants. In particular, the results indicated that the 
program was well received by participants, and resulted in a number of qualitatively 
reported positive changes following the group, such as improved emotions management, 
better communication skills, and more positive relationships with others. Moreover, all 
participants reported high satisfaction with their experience of the STEPPS programme, 
and the service concerned.  
 
There are a number of possibilities that could account for this apparent discrepancy in the 
results. Firstly, some deterioration of symptoms towards the end of therapy could be 
perceived as a predictable and understandable response in people with BPD, given their 
difficulties managing endings (Blum et al., 2002) although there was no sign of a “bounce 
back” at follow up. Secondly, the difference between qualitative and quantitative findings 
may reflect limited sensitivity of the outcome measures used in identifying more subtle 
changes in symptom severity, although this measure was designed for the purpose of 
evaluating this programme. Thirdly, the improvements reported by the clients in their 
qualitative accounts could be related to the non-specific therapy factors or process 
variables that have not been assessed in this evaluation. It is also possible that the process 
of change in such severe cases would be slower and more gradual than in previous studies, 
and may not be reflected adequately in the time concerned. This is possible given that 
severity and complexity of our sample was much higher compared to the previous research 
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(Black et al., 2008; Blum et al., 2008). For instance, Black et al. (2008) in their study of 
twelve female offenders with BPD, reported a mean score for BEST was 28 at baseline, 
which decreased to 16.9 post-treatment (Black et al., 2008). Similarly, Blum and 
colleagues in their RCT reported the mean score on BEST measure of 39, which decreased 
to 31.8 post-treatment (Blum et al., 2008). In contrast, the mean severity score on BEST 
measure in our study was 46.3, which decreased to 43.5 post-treatment. This suggests, that 
the severity scores were higher in our sample as compared to previous research (Black et 
al., 2008; Blum et al., 2008), which might explain the smaller changes in severity of BPD 
observed in this study. Furthermore, this study demonstrates the difficulties translating the 
results of available RCTs and research trials into real world clinical setting often 
characterised by complex and comorbid presentations. 
 
Finally, and most likely, the results may indicate that the programme was not effective, and 
the qualitative data reflect demand characteristics. Although participants reported that the 
program taught them new skills to better manage their disorder, this did not translate in 
clinically meaningful changes on measures used to evaluate the implementation of the 
STEPPS programme. Thus, it is possible that the results from the qualitative evaluation of 
this study were inflated due to participant knowing that the scores would be observed by 
the therapist. In particular, it is possible that positive outcomes reported in the qualitative 
feedback were due to the effects of social desirability and demand characteristics bias. 
While the participants reported improvements, those benefits might have resulted from 
extra social support, hope and therapeutic alliance received through the programme. These 
elements have been shown to be particularly important for people with BPD due to their 
histories of invalidating and unreliable environment and social relationships (Linehan, 
1993).  Alternatively, they could have occurred due to desire to report positive findings to 
please the therapist, and not the elements specific to STEPPS. Therefore, the results of this 
study does not provide support for the notion the STEPPS programme is a reasonable 
treatment option for complex cases presenting in the UK secondary care services. 
 
Limitations of the present evaluation 
However, it is important to acknowledge limitation of this study. Firstly, the results of the 
present evaluation are mixed and should be treated with caution. In addition, it is important 
to note that the generalizability of the findings is limited by a small sample size that 
consisted of females, who presented to the UK secondary care services with severe 
symptoms of BPD. Therefore, these results may not generalise to other populations or 
services. Finally, due to the lack of statistically significant changes from pre to post-
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treatment, and lack of active comparison group, this study does not allow conclusions 
about the efficacy of the STEPPS programme, or its effectiveness relative to other manual-
based treatment programs, such as DBT or CBT. More research is warranted to further 
evaluate the value of the STEPPS group in secondary care services. 
Recommendations 
The finding that the relative lack of change in quantitative measures was inconsistent with 
the qualitative findings is of particular importance, when considering future evaluation of 
services. The following section will discuss the main implications of the present 
evaluation, and how this could be applied in terms of service improvement. 
 
 Recommendations for future STEPPS groups 
 
Consider further evaluation of the STEPPS programme  
As the implementation of the STEPPS programme did not result in significant pre to post-
treatment improvements, it is crucial for the service to carefully consider future delivery of 
this treatment. Given the present findings obvious recommendation is that first and 
foremost, first and foremost, it is important not to assume the effectiveness of the STEPPS 
programme. Therefore, any continuation of STEPPS should include evaluation.  
For instance, the service could consider offering another STEPPS group tailored 
specifically for people with lower severity of BPD symptoms. Secondly, the service could 
use alternative outcome measures, such as goal-based outcomes, or measures related to 
coping and quality of life, as those factors may be more meaningful and mineable to 
change in more both severe and less severe cases.  
 
Follow-up data 
Due to lack of long-term outcome data in this study, it was not possible to establish the 
impact of the group on symptoms and functioning past 2 months. If possible, the service 
could consider collecting follow up data at 6 or 12 months.  
 
Offer STAIRWAYS to consolidate skills and prepare for therapy ending 
Service users felt that it would be helpful to have more time to consolidate their skills and 
retain a link with the service and/or other service users. Therefore, the service could 
consider introduction of STAIRWAYS programme designed to maintain the skills learned 
in STEPPS (Blum et al., 2002). This would also facilitate graded discharge from treatment 
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and better management of therapy endings and fear of abandonment commonly 
experienced by people with BPD (Blum et al., 2002).  
 
Avoid changes of group facilitators 
According to NICE (2009), staff working with service users presenting with BPD features, 
need to be careful in their handing of the therapeutic relations, particularly regarding 
attachment issues. Based on feedback from the service users, transition form one therapist 
to another during the group was perceived as difficult and potentially threatening to the 
consistency and integrity of the group. In order to maintain consistent provision of care, the 
change of group facilitators should be avoided as far as possible, with the therapists being 
able to offer a reliable time commitment prior to the group. 
 
 General service recommendations  
 
Offer choice and cooperation 
In terms of more general recommendation, it is important to offer choice and cooperation 
in all aspects of service users’ experience of the services. According to the NICE 
guidelines (2009) active involvement of service users in every aspect of their treatment is a 
crucial aspect of engagement. Therefore, service users should be involved as much as 
possible in making informed decisions about their treatment. The service should consider 
active ways of engaging service users, and should continue with their approach of offering 
an opportunity to discuss their treatment options in the initial appointment. 
 
Communication and management of the waiting times 
A clear and consistent communication is crucial to the engagement with services and 
should be considered at every stage of therapy process.  In particular, in the event of a 
delay in assessment or treatment, the service should consider communicating the reasons 
for a delay, and consider signposting clients to other sources of support if appropriate. 
 
Promote further involvement of service users’ families, partners and carers  
According to NICE guidelines it is crucial for the service to actively involve clients and 
their family, partners and carers in enhancing and improving service provision (NICE, 
2009). This is consistent with the views of the participants from the present study who 
reported that they valued input from their families and felt that this could have been 
introduced earlier on in their treatment. Therefore, it is recommended that the service 
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should consider offering more sessions to family and support systems and introduce them 
earlier on, subject to client’s choice and rights to confidentiality.  
 
Increase availability of care co-ordination 
In addition, the service should reconsider access to care coordination during the treatment. 
Given that distress can often escalate while the person is in therapy, it is recommended that 
care coordination should be increased during the STEPPS programme to enable adequate 
support for the participants. This may be particularly important in times of crisis, and 
during therapy ending. 
 
Managing endings 
Since ending therapy is often contentious to many service users, more preparation before 
therapy endings and/or discharge might be beneficial. Although therapy endings have been 
carefully planned for before the group started, the service could consider a more structured 
approach to ‘endings’ for the future groups. For instance, endings could be introduced 
earlier on within the programme. Involving service-user’s family and support system 
would also be crucial when planning therapy endings.  
 
 Recommendations for further research and evaluation 
 
Evaluation of the STEPPS programme 
Further evaluations of the STEPPS programme are warranted. It would be important to 
compare the results of the present study with findings from other evaluations of the 
STEPPS programme in order to fully asses its efficacy, and establish who is most likely to 
benefit from it.  
 
Comparison with different approaches 
Although promising from a qualitative perspective there is a need for further research 
comparing STEPPS programme to other treatment options for BPD to investigate whether 
similar outcomes can be obtained using more cost effective and less intensive model of 
STEPPS treatment.  
 
Development of outcomes measures  
It is recommended that future research should consider exploring other ways of assessing 
outcomes of interventions for people with BPD. It is possible that existing measures used 
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to assess changes in BPD may not adequately capture service user experience of change 
and changes that happen as a result of therapy process. Moreover, agreeing on a set of 
outcome measures for future studies on BPD would enable to compare the effects of 
different interventions and contribute to developing evidence base treatment guidelines for 
people with BPD (NICE, 2009). 
 
Developing a care pathway  
A future research or service evaluation could also consider using mixed-method study 
examining the care pathway of people with BPD, such as factors affecting management of 
care, and transfer between different components of care (e.g. referral from primary to 
secondary care, management of endings and discharge from services). Such a study should 
ideally include collection and analysis of both qualitative and quantitative data as 
recommended by NICE (2009). 
Summary and conclusion 
 
Overall, the present study suggests that the implementation of the STEPPS resulted in 
some positive changes as indicated by the qualitative findings of this study. This however 
has not been substantiated by the quantitative results indicating lack of statistically 
significant changes in symptoms of BPD and distress following the STEPPS groups. This 
finding is of great relevance when considering future evaluation of treatment outcomes for 
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Objective: The present study sought to investigate the extent and role of health anxiety, 
mental defeat, self-compassion and health related coping behaviours in relation to fear of 
cancer recurrence (FCR), psychological distress amongst breast cancer survivors, 
according to whether or not they had had chemotherapy as part of treatment. This 
comparison was carried out to build upon previous research findings that have pointed an 
especially adverse psychological impact of chemotherapy treatment.   
 
Methods: A total of 77 breast cancer survivors were recruited, and completed 
questionnaires in order to investigate whether more intensive treatment (i.e. including 
chemotherapy alongside radiotherapy and surgery) will be associated with higher levels of 
health anxiety, mental defeat, fear or recurrence, and psychological distress.  
 
Results: Group comparison demonstrated significantly higher levels of health anxiety, 
FCR, mental defeat and psychological distress amongst patients who have undergone more 
chemotherapy. Multiple regression analysis indicated that health anxiety, psychological 
distress and age, were the strongest predictors of fear of recurrence; while mental defeat 
and fear of recurrence were strongest for psychological distress. In addition, mental defeat 
was inversely associated with higher self-compassion. 
 
Conclusions: These results suggest that FCR, health anxiety and mental defeat is 
significantly elevated amongst breast cancer survivors, in particular those who have 
undergone chemotherapy, and is associated with increased levels of longer-term 
psychological distress. Cognitive-behavioural interventions, which target these variables, 















Increasing incidence of cancer, an aging population, and advances in early detection and 
treatment mean that the number of people living with and surviving cancer is on the rise 
and currently totals around 1.8 million in the UK (Department of Health, 2012; Maddams, 
Utley & Møller, 2012).  Whilst many cancer survivors adjust relatively well following the 
completion of active treatment (Boyes, Girgis, D’Este & Zucca, 2012), there is evidence 
that a significant proportion continue to struggle, often for many years, with a range of 
unmet psychological, social and physical needs (Armes, Crowe, Colbourne et al., 2009; 
Donovan, Thompson, & Jacobsen, 2012; Santin, Mills, Treanor & Donelly, 2012). 
Accordingly, research surrounding cancer ‘survivorship’ has gained prominence 
internationally in recent years, driven in the UK by the National Cancer Survivorship 
Initiative (NCSI; Department of Health, 2013).  In the present paper, we consider the 
empirical and theoretical understanding of psychological distress in cancer survivors.  
Cancer is known to have a profound psychological and emotional impact, with the 
prevalence of major depression and anxiety disorders two to three times higher than in the 
general population (Boyes, Girgis, D’Este & Zucca, 2011; Stark & House, 2000; Kessler, 
Wai, Demler & Walters, 2005; Levin and Alici, 2010; Miller & Massie, 2010; Pirl, 2004).   
Furthermore, up to 47% of cancer survivors express a fear of cancer recurrence (FCR; 
Department of Health, 2012), defined as the fear that cancer will recur or progress in the 
same or a different part of the body (Koch, Jansen, Brenner & Arndt, 2013).  It has been 
suggested that managing FCR is one of the most common and pronounced challenges of 
cancer survivors (Koch et al., 2013).  Although a degree of fear about disease relapse is, of 
course, entirely understandable and proportionate following cancer treatment, it can often 
become excessive, persistent and significantly disabling in terms of high levels of 
psychological distress and an associated adverse impact on quality of life (Crist & 
Grunfeld, 2012). Several recent systematic reviews have summarised the evidence in 
relation to the factors influencing FCR (e.g. Crist & Grunfeld, 2012; Koch et al., 2013, 
Park et al., 2013; Simard, Thewes, Humhris et al., 2013). The factor most consistently 
associated with increased FCR has been younger age, whilst other socio-demographic 
indices (e.g. gender, education, employment) have not proved influential.  With regard to 
medical and treatment-related factors, there have been reported differences across cancer 
types, with breast, colorectal and lung cancer associated with greater FCR (Simard, Savard 
& Ivres, 2010).  Perhaps surprisingly, stage of disease has not emerged as a reliable 
predictor of FCR (Crist & Grunfield, 2013).  By contrast, treatment type has been linked 
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with higher levels of FCR, with chemotherapy reported to be associated with greater FCR 
amongst breast cancer survivors (e.g. Constanzo et al, 2007; Janz, Hawley, Mujahid, et al., 
2011; Lasry & Constanzo, Lutgendorf, Matters, et al., 2007; Mehnert, Berg, Henrick, & 
Herschback, 2009). However, other studies with a range of cancer types found no 
relationship between treatment type and fear of recurrence (Leake, Gurrrin, & Hammond, 
2001; Rogers, Scott, Lowe, Ozakinci, & Humphris, 2010). Therefore, the evidence remains 
mixed and often contradictory overall in relation to the influence of treatment type on FCR 
(Crist & Grunfeld, 2013), and it is therefore important to further investigate and clarify 
these relationships. Much stronger evidence exists for associations between physical 
symptoms (e.g. pain, treatment side effects, fatigue) and elevated FCR (Crist & Grunfeld, 
2013), which might often be driven by the misattribution of benign somatic cues to cancer 
recurrence or progression.  In turn, protracted FCR could serve to heighten awareness and 
vigilance of physical symptoms, thus compounding and reinforcing worry and anxiety 
(Simard et al., 2013). Indeed, a number of authors have emphasised the relative importance 
of cognitive and emotional factors as opposed to medical or demographic factors in 
maintaining FCR, prompting suggestions that the subjective experience of the disease 
might influence FCR to a greater degree than its objective severity (Koch et al., 2013; 
Simard et al., 2013).   
 
Lee-Jones, Humphris, Dixon and Hatcher (1997) presented a cognitive formulation of FCR 
in a short review paper, proposing the role of internal (e.g. symptoms, somatic cues) and 
external (e.g. hospital appointments, magazine articles) stimuli in activating intrusive 
thoughts and FCR.  Both Lee-Jones et al. (1997) and a recent mindfulness-based 
intervention study (Lengacher et al., 2014) proposed FCR as a mediating variable, in turn 
influencing psychological distress and behavioural responses. Lee-Jones et al (1997) 
posited that likely behavioural responses of FCR might include excessive physical self-
examination and reassurance-seeking from health professionals. This is consistent with 
recent preliminary evidence suggesting that greater FCR was associated with higher 
frequency of unscheduled visits to GP, body self-examination, avoidance of formal cancer 
screening and more use of counseling and complementary therapy services (Lebel, Tomei, 
Feldstain et al., 2013; Thewes, Butow, Bell, Beith et al., 2012).  Interestingly, Thewes et 
al., (2012) found evidence that higher FCR was associated with excessive self-monitoring 
(e.g. checking body parts for cancer) but less frequent use of formal, prescribed, health 
practitioner administered cancer screening examinations. This is consistent with the 
cognitive-behavioural model of health anxiety, which proposes that high levels of health 
anxiety are associated with both excessive threat monitoring and avoidance behaviour 
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(Salkovskis et al., 2003; Warwick & Salkovskis, 1990). 
 
Although the cognitive-behavioural model of health anxiety has been referred to in the 
FCR literature (e.g. Lee-Jones et al., 1997; Thewes et al., 2012), its propositions have not 
been empirically investigated in the context of cancer survivorship. According to the 
model, people who experience severe and persistent anxiety about their health have a 
relatively enduring tendency to misinterpret bodily sensations and other health related 
information as signs that they currently have, or are at risk of developing, a serious medical 
illness (Salkovskis, Warwick, & Deale, 2003).  This is of particular interest, as both FCR 
and health anxiety are characterised by preoccupation with physical symptoms and 
heightened perceptions of risk of serious illness (or its recurrence).  Thus, individuals 
inclined towards health anxiety could be especially susceptible to developing chronic FCR, 
driven by hypervigilance to signs of danger, selective attention to threat information, 
excessive monitoring of their body for signs of cancer, or avoidance of reminders of cancer 
and treatment (Crist & Grunfield, 2013).  
 
Anxiety is not the only psychological response to cancer. Brennan (2004) has described the 
attritional experience of living with relentless anxiety and fear of cancer relapse, often 
resulting in a profound loss of confidence and sense of control, and leading to a withdrawal 
from valued goals and activities in life.  This description resonates with the construct of 
‘mental defeat’, which is a relatively recently identified cognitive phenomenon capturing 
the loss of autonomy and negative self-beliefs prominent in chronic pain sufferers (Tang et 
al., 2007, 2010).  Research in chronic pain patients has identified mental defeat as a 
powerful predictor of anxiety, depression and psychosocial disability (Tang et al, 2007, 
2010).  Persistent chronic pain is a major clinical problem affecting 25 to 60% of breast 
cancer survivors (Andersen & Kehlet, 2011), compounding the already psychologically 
and emotionally arduous treatment and recovery pathway.  Accordingly, the construct of 
mental defeat might offer important insights into cancer survivorship, particularly in terms 
of its relationship to other psychological factors such as FCR and health anxiety.   
 
Although psychological distress in people suffering from chronic and life-threatening 
conditions are highly prevalent (Evans et al., 2005), research into factors that may protect 
people from developing emotional difficulties remains scare. Neff (2003, 2009) has 
defined self-compassion as comprising of three elements: self-kindness, which refers to the 
ability to treat oneself with care rather than self-judgement; common humanity which 
refers to a recognition that suffering is a shared aspect of the human experience; and 
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mindfulness. According to this proposal, individuals who are self-compassionate are more 
likely to respond with awareness, understanding and self-kindness when faced with 
difficult life events and emotional distress (Przezdziecki et al., 2013). Recent developments 
in this field have pointed out to self-compassion as a potentially relevant construct in 
relation to the experience of physical illness (Costa & Pinto-Gouveia, 2010; Wren et al., 
2011). Moreover, it has been suggested self-compassion is associated with improved 
psychological well-being and might be an important factor for fostering emotional 
resilience (Neff, 2009; Przezdziecki et al., 2013). Previous studies highlighted a significant 
relationship between higher levels of self-compassion and lower depression and anxiety 
scores (Leary, Tate, Adams, Allen, & Hancock, 2007; Van Dam, Sheppard, Forsyth, & 
Earlywine, 2011). Self-compassion has also been suggested as an important factor that 
could enhance adaptive responses to illness, such as emotional self-regulation and adoption 
of positive health-related behaviours that promote health and well-being (Terry & Leary, 
2011). More recently, research evidence indicated the protective role of self-compassion in 
relation to depression and anxiety, and quality of life in patients with cancer and chronic 
physical health conditions (Pinto‐ Gouveia, Duarte, Matos, & Fráguas, 2014). 
Furthermore, low self-compassion has been found to mediate the association between 
psychological distress and body image disturbance among breast cancer survivors 
(Przezdziecki et al., 2013). Thus, the construct of self-compassion may offer a valuable 
insight into protective factors that could prevent one from developing elevated levels of 
mental defeat and, in turn, severe and protracted psychological distress following cancer 
diagnosis and treatment. 
 
In summary, despite an increasing research interest in FCR over recent years, the empirical 
literature remains largely atheoretical in terms of understanding and defining the 
relationships between key psychological parameters.  Existing evidence points towards the 
importance of subjective interpretations of physical symptoms in provoking intrusive 
thoughts and FCR, which can then prompt excessive self-monitoring and reassurance-
seeking behaviours.  Type of cancer treatment has also been found to influence threat 
appraisals surrounding cancer relapse, although the evidence to date is mixed and 
inconclusive.  Further efforts to elucidate cognitive and emotional factors underpinning 
FCR offers the prospect of designing targeted cognitive-behavioural interventions, building 
upon a recent successful trial of CBT for health anxiety in medical settings (Tyrer et al., 
2014).  To these ends, the present study seeks to investigate the role of health anxiety, 
mental defeat and self-compassion in relation to FCR and health related coping behaviours. 
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Aims and objectives 
The primary aims of this study were: (1) to investigate the extent to which health anxiety, 
mental defeat and self-compassion are associated with FCR, psychological distress and 
dysfunctional behavioural responses including excessive self-monitoring and reassurance-
seeking from health professionals; (2) and to explore whether type of treatment is 
associated with degree of health anxiety, mental defeat, self-compassion, as well as FCR, 
psychological distress, and health related coping behaviours.  
 
Hypotheses 
It was hypothesised that: 
1. More intensive treatment (i.e. including chemotherapy alongside radiotherapy and 
surgery) will be associated with higher levels of health anxiety, mental defeat, fear or 
recurrence, and psychological distress.  
2.1 Health anxiety, mental defeat will be positively related to, and will predict FCR 
(controlling for known confounding variables such as age). 
2.2 Health anxiety, mental defeat and fear of recurrence will be related to, and will predict 
psychological distress in breast cancer survivors.  
 
In addition, the current study included the following exploratory hypotheses:  
3. Higher levels of self-compassion will be negatively associated with mental defeat and 
psychological distress. 
4. Higher levels of FCR and health anxiety will be associated with increased maladaptive 




This study utilised a cross-sectional questionnaire design to explore the influence of health 
anxiety, mental defeat and self-compassion on levels of FCR, psychological distress, and 
reassurance-seeking health behaviours amongst a sample of breast cancer survivors. The 
study also examined differences in the above variables between participant groupings 
according to treatment protocol. 
 
Participants  
Participants included 77 female breast cancer survivors (mean age M=54, SD=9.7, range 
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34-84), who were recruited through an advertisement on the Macmillan Cancer Voices 
network, and follow-up review clinics at the Oncology Centre in the Royal United Hospital 
in Bath, Breast Cancer Centre in the Southmead Hospital in Bristol, and Great Western 
Hospital in Swindon. For the purposes of this study, ‘breast cancer survivor’ was defined 
as a person who has had a diagnosis of breast cancer and has completed primary treatment 
with curative intent and was presently clear of disease.  
 
Inclusion criteria were: (1) aged 18 or over; (2) confirmed past diagnosis of breast cancer 
(Stages 0-III); (3) completed primary treatment with curative intent; (4) patients may still 
be in receipt of treatment to reduce the risk of disease relapse (e.g. hormonal treatment) or 
for cosmetic reasons related to breast reconstruction surgery; (5) no time limit was set for 
the time since diagnosis. 
 
Exclusion criteria were: (1) patients who lack capacity to consent to participation (e.g. due 
to dementia, learning disability, or other cognitive impairment). 
 
In line with the study aims and hypotheses, patients were divided into two groups 
according to their primary treatment protocol to permit between-groups analyses, as 
follows: (1) surgery; surgery + radiotherapy; (2) surgery + chemotherapy; surgery + 
radiotherapy + chemotherapy. The above groups had been arranged in order of increasing 
treatment intensity and invasiveness, guided by the existing research literature and 
consultation with local Consultant Oncologists.  
Measures 
 
Demographic and clinical characteristics 
Participants were asked to provide information about their age, level of education, 
relationship and employment status. Concerning breast cancer diagnosis, participants 
indicated time since diagnosis, time since completion of treatment, and type of treatment. 
 
Health Anxiety  
Health anxiety was measured using the Health Anxiety Inventory – Short Form (HAI-SF; 
Salkovskis, Rimes, Warwick & Clark, 2002). The HAI is a short 14 item self-report 
questionnaire measured on a 0 to 3 scale with higher scores indicating higher levels of 
health anxiety. The HAI-FS is a reliable and valid measure with comparable psychometric 
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properties to the full-length scale, good internal consistency and test-retest reliability 
(Salkovskis et al., 2002).  
 
Mental defeat 
Mental defeat was measured on adapted version of The Pain Self Perception Scale (PSPS; 
Tang, Salkovskis, & Hanna, 2007). The original PSPS assesses perceptions of defeat 
associated with a recent episode of intense pain. It includes 24 item rated for their 
applicability during the pain episode. The higher scores represent the higher levels of 
mental defeat. The PSPS was adapted to measure mental defeat in cancer survivors in 
response to their experience of cancer. 
 
Self-compassion 
Self-compassion was measured using the 12-item Self-Compassion Scale - Short Form 
(SCS-SF; Raes, Pommier, Neff, & Van Gucht, 2011), which has good psychometric 
properties and a near perfect correlation (r = .97) with the long form. Internal consistency 
reliability of the measure is α = .86. The SCS-SF is composed of 12 items measured on a 
5-point Likert scale, ranging from 1 (almost never) to 5 (almost always). The higher scores 
represent the higher levels of self-compassion. This scale comprises a positive component 
that includes self-kindness, common humanity and mindfulness subscales; and a negative 
one comprising of self-judgment, isolation, and over-identification.  
 
Fear of cancer recurrence 
The Fear of Cancer Recurrence Inventory-Severity Subscale (FCRI-SS; Simrad & Savard, 
2009) is a 9 item scale that was used to measure the presence and severity of intrusive 
thoughts associated with FCR. The FCRI-SS is derived from The Fear of Cancer 
Recurrence Inventory that is a comprehensive, multidimensional scale with high internal 
consistency (Cronbach’s α = 0.95) and good test-retest reliability, and is intended for use 
with all cancer patients (Simrad & Savard, 2008, 2009). Responses are rated on a 4-point 
Likert scale. The scores range from 0-36, with the higher scores representing higher levels 
of FCR. The cut-off score of 13 on the FCRI Severity Subscale was associated with 
optimal sensitivity (88%) and specificity (75%) rates for the detection of clinical levels of 








The PHQ-9 (Kroenke, Spitzer & Williams, 2001) is a valid and reliable self-report 
inventory that was used as a screening tool for severity of depression.  The PHQ-9 total 




The GAD-7 (Spitzer et al., 2006) is a 7-item scale that was used as a screening for 
generalised anxiety disorder.  A total score for the seven items ranges from 0 to 21, with 
higher scores representing higher levels of anxiety.  The measure has good psychometric 
properties with sensitivity of 0.89 and specificity of 0.82 (Spitzer et al., 2006). 
 
Health related coping behaviours 
Following Thewes et al. (2012), five single-item questions were employed to assess: (1) 
the number of times the participants had visited their GP and Oncologist or Specialist 
Nurse to discuss potential symptoms of recurrence in the past 12 months; (2) the number of 
GP visits for any reason in the past 12 months; and (3) the frequency of breast or body self-
examination. In addition, two single-item questions related to (4) the use of the Internet 
and (5) verbal reassurance from significant others were also included.   
Procedure 
Suitable participants were identified in liaison with the cancer service clinicians. 
Consultant Oncologists and other clinical staff assisted in identifying eligible participants. 
A study advertisement was also posted on Macmillan Cancer Voices website. The 
participants willing to take part in the study were provided with an information sheet, 
consent form, questionnaire pack and a pre-paid envelope to be returned to the researcher. 
Participants were encouraged to contact the research team with any questions or concerns 
about the study. They were given the option to complete the questionnaire alone or with 
support from a friend or family member in their home or at clinic.  
 
Analytic strategy  
Analyses were performed using SPSS 22 (SPSS Inc. IBM, Chicago, Illinois, USA), with 
statistical significance set at p< 0.05. Data were screened for univariate outliers, missing 
data and violations to the assumptions of multivariate analysis. Descriptive statistics were 
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used to describe demographic and clinical characteristics of the sample. As demographic 
variables, such as age (Simard, Savard & Ivres, 2010)) may influence fear of recurrence, 
this variable was considered as potential covariates in the analysis. For the type of 
treatment, an independent samples t-test was performed to examine differences between 
the two groups on health anxiety, mental defeat, self-compassion, FCR, and psychological 
distress, and reassurance-seeking health behaviours (hypothesis 1). A series of multiple 
linear regression analyses was performed to examine the individual strength of health 
anxiety, mental defeat and self-compassion, and age in predicting FCR and psychological 
distress (hypothesis 2). These analyses avoided the problem of multicollinearity and 
permitted a focused evaluation of the key predictor variables of interest in this study. 
Finally, correlation analyses were conducted to explore the relationship between self-
compassion and mental defeat (hypothesis 3), and the relationship between health anxiety, 
FCR and reassurance-seeking health behaviours (hypothesis 4). In addition, regression 
analyses were also conducted to explore the extent to which health anxiety and fear of 
recurrence can account for health related coping behaviours.  
 
Collinearity diagnostics were conducted using the variance inflation factor (VIF) and the 
tolerance statistics to investigate if the data met the assumptions of collinearity. There are 
few guidelines that can be applied when interpreting the results of the collinearity 
diagnostics. If the VIF is greater than 10 then there is cause for concern. If the average VIF 
is substantially greater than 1 then the regression may be biased. Tolerance level below 0.1 
indicates a serious problem, while tolerance below 0.2 indicates a potential problem (Field, 
2009). The results of these test indicated that multiple collinearity was not a concern, and 
that these data were adequate for regression analyses. 
 
Power considerations 
A priori power analysis using G*Power (Faul et al., 2009) was calculated and indicated a 
required sample size of 60, to achieve an effect size of 0.4, power 0.8, alpha 0.05. 
 
Involvement of people with personal experience 
People with personal experience of cancer were consulted to ensure that the research 
protocol, information sheet and questionnaire pack were clear, concise, and acceptable to 
other patients. Piloting was undertaken with one patient to ascertain feasibility in terms of 
time needed for participants to complete the questionnaires. This was considered 
appropriate given the possibility of high levels of fatigue in some cancer survivors.  
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Governance procedures and ethical considerations 
This study was approved by the West of Scotland NHS Research Ethics Committee 
(REC; Reference: 14/WS/1018), the University of Bath Psychology Research 
Ethics Committee (Reference: 14-174), and the Research and Development (R&D) 
Team from the local NHS Trusts involved in data collection.  
Results  
Demographic and clinical characteristics are presented in Tables 1 and 2 below.  
 
Table 1. Sample demographic and clinical characteristics of the participants 
 
Variable Chemotherapy  
Number (%) 
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     Black 
     Mixed background 
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     No formal qualification 
     Primary 
     Secondary 
     Diploma 
     Degree 
     Postgraduate 



























     Paid work 
     Unpaid work 
     On sick leave 
     Unemployed 
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     In a relationship 
     Cohabiting 
     Engaged 
     Married 
     Divorced 












































51.6 (SD=7.2) 59.6 (SD=12.4) 54.0 (SD=9.7) 
Health Anxiety 
 
15.8 (SD=6.6) *** 
(0-42) 
 














































5.0 (SD=4.5) * 
(0-21) 






































Time since diagnosis 
     Less than 1 year 
     1-2 years 
     2-3 years 
     3-4 years 
     4-5 years 























Chemotherapy and no chemotherapy group comparisons (hypothesis 1)  
Independent samples t-tests were conducted to compare the chemotherapy with no 
chemotherapy groups on measures of fear of recurrence, health anxiety, mental defeat, 
depression and anxiety. The results indicated significant differences between 
chemotherapy and no chemotherapy group in the scores for health anxiety t=(72)= -3.22, 
p< .001; fear of recurrence t(72)= -4.01, p< .0001; and generalized anxiety, t(70)= -3.27, 
p< .005. 
 
Levene’s test for equality of variances was found to be significant for some variables  
(mental defeat, depression and total scores for psychological distress). For mental defeat 
F(1,72)=5.64, p= .02, a t-test not assuming homogeneous variances indicated that there 
was a significant difference in mental defeat observed between the two groups, t(72)= -
2.90, p< .005. Similarly, homogeneity of variance was violated for depression 
F(1,72)=6.50, p= .013. A t-test not assuming equal variances was then calculated and 
revealed significant differences between two groups on depression scores, t(72)= -3.76, p < 
.0001. The groups were also significantly different on the measure of total distress 
F(1,72)=5.48, p=0.02; t(72)= -4.16, p< .0001. Finally, the chemotherapy and no 
chemotherapy groups were not significantly different on measures on self-compassion and 
health related coping behaviours. 
 
Regression analysis - fear of recurrence (hypothesis 2.1) 
A multiple linear regression analysis was performed to examine the individual strength of 
health anxiety and mental defeat in predicting fear of recurrence; and the strength of health 
anxiety, mental defeat and fear of recurrence in predicting psychological distress. 
Regarding fear of recurrence, a significant model accounting for 63% of the variance in 
fear of recurrence was produced. Health anxiety emerged as the best predictor of fear or 
recurrence controlling for age, followed by mental defeat, as illustrated in Table 3.  
 
Table 3. Model summary and Beta values for the multiple regression for fear or recurrence 
variable 
 
Model R2 Adjusted R2 F B β t 
Age .211 .201 19.8 - .132 - .157 -1.994* 
Health anxiety  .624 .614 60.8 .720 .625 6.621**** 
Mental defeat .646 .631 43.7 .090 -.175 2.07* 
β – standardized regression coefficient; *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001 
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Regression analysis – psychological distress (hypothesis 2.2) 
Regarding psychological distress, a significant model accounting for 69% of the total 
variability in psychological distress was found. Mental defeat emerged as the best predictor 
of psychological distress, followed by fear of recurrence, as illustrated in Table 4. Health 
anxiety did not appear to be a significant predictor of psychological distress. 
 
Table 4. Model summary and Beta values for the multiple regression for psychological 
distress  
Model R2 Adjusted R2 F B β t 
Mental defeat .661 .657 146.40 .416 .676 8.662**** 
Fear of recurrence .702 .694 87.150 .247 .207 1.982* 
Health anxiety .703 .691 57.546 .067 .048 .454 




Association between self-compassion and mental defeat (hypothesis 3) 
A Pearson correlation was calculated in order to explore the relationship between self-
compassion and mental defeat. The results indicated a significant negative relationship 
between self-compassion and mental defeat r= -.54, p< .0001. Self-compassion was also 
negatively associated with health anxiety, r= -.34, p< .005; fear of recurrence, r= -.33, p< 
.005; and psychological distress r= -.502, p< .0001. 
 
Association between health anxiety, fear or recurrence, and health related coping 
behaviours (hypothesis 4) 
A Pearson correlation indicated that health related coping behaviours (e.g. breast and body 
examinations; Internet use to seek health related information; and reassurance seeking 
from others) were significantly associated with health anxiety (r=.51, p< .0001), and fear 
of recurrence (r=.52, p< .0001). 
 
Body checking, reassurance seeking, and health related Internet use  
A multiple regression was conducted to investigate whether health anxiety, fear of 
recurrence, mental defeat, self-compassion, age and time since diagnosis could predict the 
variance in breast and body self-examination. The results indicated that fear or recurrence 
was the only significant predictor of the variance in the frequency of breast and body 
examination (β= .34, p< .005), and accounted for about 10% of the variance in body 
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checking behaviours (R2= .10, F(1,69)= 8.95, p< .005.  
 
Health anxiety emerged as the only significant predictor of reassurance seeking (β= .53, p< 
.0001), and health related Internet use (β= .63, p< .0001). More specifically, health anxiety 
accounted for 28% of the variance in reassurance seeking behaviours (R2= .28, F(1,69)= 
26.9, p< .0001), and 40% of the variance in the health related Internet use (R2= .40, 
F(1,69)= 46.2, p< .0001). 
 
The three items (i.e. breast/body examination; Internet use to seek health related 
information; and reassurance seeking) demonstrated acceptable internal consistency, α= 
.65. The independent samples t-test, revealed that the chemotherapy group reported 
significantly more use of the Internet for health related information, as compared to no 
chemotherapy group, t(72)= -2.73, p< .005. There were no significant differences between 
the two groups on their body self-examination or reassurance seeking behaviours.  
 
Relationship between fear or recurrence and medical variables 
 
Pearson correlation was calculated in order to establish whether fear of recurrence and 
health anxiety is significantly associated with medical factors, such as time since diagnosis, 
time since end of treatment, and duration of treatment. The results indicated that duration 
of treatment was the only medical variable that was significantly correlated with health 
anxiety, r= .24, p< .05. An independent sample t-test was then calculated to examine if 
chemotherapy and no chemotherapy group differed on duration on treatment. The results 




The primary aims of this study were to investigate the extent to which health anxiety, 
mental defeat and self-compassion are associated with FCR, psychological distress and 
health-related coping behaviours; and to explore the impact of type of cancer treatment on 
psychological outcomes in breast cancer survivors. 
 
Our results indicated that a significant proportion of breast cancer survivors are at risk of 
experiencing high levels of health anxiety and FCR, with 71% of our sample reporting 
clinically significant levels of FCR.  
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Furthermore, we found that women had undergone more extensive treatment including 
chemotherapy showed significantly higher levels of FCR, health anxiety, mental defeat, 
and psychological distress. Health anxiety and to a lesser degree mental defeat were the 
best overall predictors of FCR, when age was controlled for. In addition, mental defeat, 
and fear of recurrence emerged as the best predictors of psychological distress. Finally, as 
hypothesized, our results indicated that health anxiety and FCR were significantly 
associated with health-related coping behaviours (e.g. breast and body examinations; 
Internet use to seek health related information; and reassurance seeking from others).  
 
These findings highlight the therapeutic value of the cognitive health anxiety model in 
guiding psychological support interventions for breast cancer survivors struggling with 
FCR, and are consistent with previous research indicating the usefulness of CBT treatment 
within medical setting (Tyrer et al., 2014). Although health anxiety has been previously 
mentioned in the FCR literature (e.g. Lee- Jones et al., 1997; Thewes et al., 2012), to our 
knowledge, the present study was the first one to specifically and empirically investigate 
the role of health anxiety in relation to FCR and psychological distress in breast cancer 
survivors. Furthermore, this study provided evidence for the important role of mental 
defeat in undermining psychological adjustment following cancer treatment. This is in line 
with previous studies investigating the role of mental defeat in cancer (Howe, Lagerdahl, 
& Salkovskis, 2014) and pain-related disability and distress (Tang et al., 2010).  
 
Previous research into FCR has revealed mixed and inconclusive evidence for the impact 
of treatment type on fear of cancer recurrence and psychological distress (e.g. Crist & 
Garfund, 2013), although adverse psychological effects following chemotherapy treatment, 
in particular, have been reported (e.g. Constanzo et al., 2007; Koch et al., 2013; Mehnert et 
al., 2009). Our study has added further weight to this trend, indicating that women who had 
previously received more intensive treatment (i.e. including chemotherapy) reported 
significantly higher levels of fear of recurrence, health anxiety, mental defeat, and 
psychological distress.  It seems highly probable that the longer duration and more severe 
side effects associated with chemotherapy, as compared to surgery or radiotherapy, results 
in heightened health related worry and anxiety about recurrence (Constanzo et al., 2007), 
together with a sense of feeling mentally defeated. Furthermore, chemotherapy treatment 
can be indicated for patients receiving a less favourable initial diagnosis, and accordingly, 
this could prompt hyper-vigilance to bodily sensations, which may be more readily 
interpreted as signs of recurrence (Constanzo et al., 2007). 
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Interestingly, mental defeat, not FCR, was the strongest and almost the only predictor of 
distress in our sample. This finding indicates that mental defeat, and its potential impact of 
sense of self and identity, could be important factor to target in therapeutic interventions 
for breast cancer survivors. Furthermore, our exploratory results indicated that self-
compassion was inversely associated with mental defeat and psychological distress. These 
findings are in line with other studies reporting self-compassion as a significant predictor 
of good adjustment and coping with body image concerns amongst women with breast 
cancer (Przezdziecki et al., 2013), and people with other physical health conditions (Costa 
& Pinto-Gouveia, 2010; Pinto‐ Gouveia, Duarte, Matos, & Fraguas, 2014). However, 
correlational data of the type found in the current study do not allow any strong inferences 
to be made regarding causality. Nevertheless, these findings add to existing knowledge and 
provide preliminary support for the notion that self-compassion may offer a protective or 
buffering effect against mental defeat and psychological distress amongst cancer survivors 




Limitations of the present study include the homogenous nature of the sample: almost all 
participants were White British, and the vast majority were married and well educated. In 
addition, data were collected through self-report measures and were based on a self-
selected group of women with a history of breast cancer. Due to the focus of this study on 
FCR, it is possible that women who were experiencing elevated levels of health anxiety 
and worry about cancer recurrence may have been more likely to participate in such a 
study. Furthermore, although we found that FCR was the only predictor of breast and body 
self-examination, it only explained a small amount of variance in breast and body 
examination, which may not be maladaptive. Finally, it is important to note that although 
psychological distress measures used in this study this study (i.e. PHQ-9 and GAD-7) are 
often used in research in medical setting, they have not been validated for the use with 
cancer survivors and may not be particularly sensitive for this population.  
 
Research and clinical implications 
 
The present study provides relatively robust evidence for (1) elevated levels of FCR and 
health anxiety in breast cancer survivors and (2) the importance of mental defeat in 
predicting psychological distress following cancer, and (3) a potential role of self-
compassion as a protective/resilience factor. Prospective studies are therefore needed to 
identify the extent to which there are causal links between these factors. Furthermore, more 
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intervention research is warranted for FCR, health anxiety, as well as risk factors, such as 
mental defeat in cancer survivors. Although research evidence supports CBT as an 
effective approach for health anxiety in medical setting (Tyrer et al., 2014), this treatment 
is yet to be evaluated in research trials in cancer survivors. Finally, our study provided 
preliminary support for the notion that fear of recurrence may mediate the relationship 
between health anxiety and distress, and that self-compassion could moderate the 
relationship between mental defeat and distress. However, more research is needed to 
evaluate this model.  
 
In terms of clinical implications, this study suggests that, in addition to distress, health 
anxiety, fear of recurrence and mental defeat could be monitored in cancer survivors, as 
they may contribute to psychological distress and may offer the prospect of designing 
targeted cognitive-behavioural interventions, and even preventative strategies to address 
FCR and mental defeat in cancer survivors. Moreover, this study suggests that addressing 
self-compassion might be a promising intervention for breast cancer survivors struggling 
with feelings of mental defeat and psychological distress. As mental defeat was an 
important predictor of levels of distress, it would be important for clinicians to consider 
that many people may feel ‘defeated’ by their experience of cancer, which can contribute 
to their distress. Given the self-critical thinking associated with mental defeat, compassion-
focused approaches may be helpful to promote more kindness and understanding in 





In conclusion, the present study clearly indicated elevated levels of health anxiety, FCR, 
and mental defeat amongst breast cancer survivors, particularly in those who have 
undergone more intensive treatment. Our research provides evidence for the importance of 
health anxiety and mental defeat with regard to fear of recurrence and psychological 
distress experienced by breast cancer survivors, and the potential protective role of self-
compassion against psychological distress in this population. This provides a sound 
evidence for further exploration of appropriate clinical interventions targeting FCR, health 
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Executive summary/ dissemination document for main research paper 
 
Fear of cancer recurrence and health behaviours in breast cancer survivors: the role 
of health anxiety, mental defeat and self-compassion. 
 
Background 
Increasing incidence of cancer, an aging population, and advances in early detection and 
treatment mean that the number of people living with and surviving cancer is on the rise. 
Cancer exerts a profound psychological and emotional impact, with the prevalence of 
major depression and anxiety disorders two to three times higher than in the general 
population. Furthermore, up to 47% of cancer survivors express a fear of cancer 
recurrence, which can often become excessive, persistent and significantly disabling. 
Therefore, the present study sought to investigate the role of health anxiety, mental defeat 
and self-compassion in relation to fear of cancer recurrence (FCR), psychological distress 
and health behaviours amongst breast cancer survivors.  
 
Method 
The present study included 77 breast cancer survivors, who were divided into two groups 
based on their treatment history (chemotherapy vs. no chemotherapy group). 
Questionnaires where used to assess levels of health anxiety, mental defeat, fear of 
recurrence, psychological distress, and health related coping. Participants were also asked 
to provide their demographic and treatment related information.  
 
Results 
The results illustrated that breast cancer survivors who had undergone chemotherapy 
treatment had significantly higher levels of psychological distress, fear of cancer 
recurrence and health related worries. They were also more mentally defeated by the 
experience of their cancer, as compared to patients with less extensive treatment.  
Our results also show that fear of cancer recurrence can be accounted for by the severity of 
one’s health worries, psychological distress and age (with younger age being associated 
with more extensive fear of cancer recurrence). In addition, psychological distress, 
including depression and anxiety, was accounted by the feelings of mental defeat and 
worries about recurrence. In addition, self-compassion was related to lower level of 




In summary, this study suggests that fear of recurrence, health anxiety and mental defeat is 
significantly elevated amongst breast cancer survivors, in particular those who have 
undergone chemotherapy, and is associated with increased psychological distress. Further 
efforts to elucidate cognitive and emotional factors underpinning FCR offers the prospect 
of designing targeted cognitive-behavioural interventions. 
 
Implications for research 
 This study investigated the role of fear of recurrence, health anxiety, mental defeat 
and self-compassion in breast cancer survivors. Further research with different 
types of cancer is required to explore the contribution of these variables to fear of 
recurrence in people with other types of cancer. 
 More research is needed to test the effectiveness of health anxiety model as a 
treatment option for fear of recurrence.  
 Further research could also explore the protective role of self-compassion and it’s 
role in reducing psychological distress and mental defeat amongst cancer survivors.  
 More research on the role of mental defeat in cancer patients is needed, including 
research on therapeutic interventions that could address mental defeat. 
 Finally, future research should investigate the differences in chemotherapy types 
received in terms in terms of psychological outcomes, including fear of recurrence, 
psychological distress and mental defeat.  
 
Implications for clinical practice 
 High level of health anxiety and fear of recurrence reported in this study suggest 
that screening for clinical levels of fear of recurrence and health anxiety is needed 
to identify people who may benefit from psychological treatment to address these 
difficulties.   
 Fear of cancer recurrence and health anxiety may be largely unrecognised and 
untreated amongst cancer survivors. Clinicians should be aware that cancer 
survivors are likely to present with elevated levels of fear of recurrence and health 
anxiety, and should consider referral to psychological support, where appropriate.  
 More information provision is needed for cancer survivors regarding distress 
related to worries about recurrence and effective ways of dealing with it.  
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 Psychological health services should consider collaborating with other 
professionals to ensure that a clear treatment pathway exists for cancer survivors 
with clinically significant levels of fear of recurrence. 
 Clinicians should be aware of the potential protective role of self-compassion 
against feelings of mental defeat. Treatment focusing on increasing self-compassion 
can facilitate psychological well-being amongst breast cancer survivors. 
 Health anxiety and mental defeat might well be involved in the development and 
maintenance of fear of cancer recurrence and psychological distress among cancer 
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Development of research ideas 
Prior to my training in Clinical Psychology I had trained as a Clinical Associate in Applied 
Psychology (CAAP) and developed interest in evidence based treatment, such as cognitive 
behavioural therapy (CBT), mindfulness-based approaches and trauma-informed treatment 
models for psychosis. I had also worked as an Assistant Psychologist in Clinical Health 
Psychology across a range of services including Oncology, Palliative Care, and HIV 
service. These experiences shaped my current clinical and research interests as illustrated 
in my research portfolio. During the first year of my training I met with my clinical and 
research tutors and supervisors who helped me to further develop ideas for potential 
research projects. Being passionate about improving the well-being of people with physical 
and mental health difficulties, I strived to develop research ideas that would inspire future 
research and clinical practice. Therefore, people with mental health difficulties were 
always in my mind when developing and shaping my research projects. 
 
Review of the Literature  
Prior to my training I became particularly interested in the relationship between trauma and 
psychosis. In order to develop my understanding of the development of psychosis, I 
decided that it would be interesting to review research into trauma and schemas, and its 
role in the development of psychosis. When I looked at the literature in this area, I realised 
that there are a number of existing reviews considering the relationship between trauma 
and psychosis, however, comparatively less research has been carried out in relation to the 
role of schemas and trauma in psychosis. Therefore, I decided that this might be an 
interesting and relevant topic to explore. Following a number of meetings with Lorna 
Hogg, who helped me to shape and narrow down my ideas, I carried out a literature search 
to further check the feasibility of this topic. I then decided to focus my review on research 
investigating schemas in people with psychosis and those with clinical high risk of 
developing psychosis, with the view to provide directions for further research and clinical 
practice. I believe that this review is timely and relevant, given growing research interest in 
this area, and the lack of previous reviews summarising the role of schemas in psychosis. It 
was an interesting learning experience for me that changed the way I see, and understand, 





Service Improvement Project 
During my first placement, I became interested in the effectiveness of new therapeutic 
approaches for people with severe and complex mental health difficulties. In particular, I 
became interested in psychological treatment for people with a diagnosis of Borderline 
Personality Disorder (BPD). Having looked at the National Institute for Health and Care 
Excellence (NICE) guidelines, I was struck that despite an increasing body of research 
evaluating psychological treatment for patients with BPD, the evidence for the 
effectiveness of different therapeutic models for this population is inconclusive. The 
service I was based in for my adult mental health placement was struggling with an 
increased demand for treatment for people with complex mental health problems and 
symptoms of BPD. Consequently, the service providers proposed setting up a pilot 
STEPPS group that would constitute an additional treatment choice for people with BPD. 
When I researched the literature in this field I found a surprising paucity of studies 
examining effectiveness of the STEPPS programme within a UK secondary care service. 
This presented an interesting opportunity to evaluate the outcomes of a pilot 
implementation of the STEPPS programme offered within our service, and contribute to 
the evidence base for this treatment. In subsequent consultation within the psychology 
team in that service, we focused on establishing the most appropriate set up of the group, 
and outcomes measures that would be used to evaluate outcomes of this programme. It was 
agreed that I would evaluate data from the STEPPS programme to offer recommendations 
for service improvement, with the aims of improving therapy offered to people with BPD.  
The paper included in this portfolio presents the evaluation of this project, and a summary 
of the main findings and recommendation for clinical practice and research. 
 
Main Research Project 
Given that my literature review and service improvement projects had focused on complex 
adult mental health, I felt that it was important to use my main research project as an 
opportunity to learn about something related to clinical health psychology. In particular, 
prior to my training I had developed an interest in psycho-oncology, and I was keen to 
create more learning opportunities in order to further develop my knowledge in this field. 
Following initial meetings with Dr Jo Daniels and Professor Paul Salkovskis, I began to 
shape my ideas regarding what would be the most helpful topic to research. Initially, I was 
interested in examining the effects of rumination and worry on psychological well-being 
and quality of life amongst cancer patients. This was inspired by emerging research on the 
usefulness of rumination-focused therapy for depression, and its potential use in clinical 
health settings. However, after reviewing the literature, I realised that there was a lot of 
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research that has already been done on rumination and worry in the context of cancer. Over 
time, having done more reading into this field, I came across emerging research area 
related to fear of cancer recurrence. I was interested in the clinical implications of that 
research, and the ways in which fear of cancer recurrence could be best addressed in 
therapy. This enabled me to narrow down my research idea further: with a specific focus 
on worries about cancer recurrence and associated distress. Following a number of 
meetings with my field supervisor Dr Andrew Medley and Professor Paul Salkovskis, we 
wondered whether exploring the role of health anxiety could be proved fruitful in this area. 
We also wondered about the influence of additional psychological factors such as self-
compassion and mental defeat on the experience of fear of recurrence and psychological 
distress. This research has proved extremely rewarding, and was in keeping with my 
interests in clinical health psychology, and improved my understanding of psychological 
models and their application to clinical practice more generally. 
 
Case Studies 
The case studies included in this portfolio demonstrate theory-practice links. They also aim 
to illustrate that our therapeutic work in clinical psychology is underpinned by our ability 
to apply psychological models and theories, a reflective formulation driven way. In most of 
my case studies I followed the same structure linking relevant background literature with a 
case study description, and a summary of assessment, formulation and intervention. This 
process helped me clarify my hypothesis related to the specific case, and decide how to 
best intervene. On all my placements I tried to ensure that I had used enough outcome 
measures to enable me to write any case up as a case study. This was a helpful habit to 
develop during training. I found the process of writing up case studies extremely useful 
and central to my clinical training, and reflection on my own practice. In particular, it 
illustrated to me the importance of evidence-based practice, inclusion of outcome 
measures, and evaluation of treatment outcomes.  
 
The reports presented in my case study portfolio cover a range of clients, contexts and 
evidence-based interventions. They also present some limits and challenges, especially due 
to the opportunists offered through individual placements. I found feedback on individual 
case studies from clinical tutors and placement supervisors extremely helpful in terms of 
learning and reflecting on a range of alternative formulations, treatment models and 
research issues. Furthermore, the case studies enabled me to reflect on therapy processes 
and the way in which systemic factors, ethical and professional issues interact and impact 
on our work and outcomes of therapy. The collection of case studies therefore represents 
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integration of theoretical knowledge with clinical practice, and my development as a 
clinician, and future clinical psychologist.  
 
Involvement of service users 
In recent years various research charities and organisations have emphasised the 
importance of service user involvement in clinical research. I was fortunate to be able to 
consult with some service user in my main research project. However, unfortunately I was 
unable to do so in my other two pieces of research. This was disappointing, because I am a 
strong believer that service users have the experience and skills to contribute to the 
development of research ideas and design. If the needs and views of the service users are 
included in the research process, it is more likely to produce clinically relevant findings. 
 
The main service user involvement in my research project included contribution that came 
from a lady who agreed to pilot our questionnaires and information sheet about the study. 
This enabled us to make specific adaptations to our inclusion criteria (e.g. upper age limit), 
and ensured that the selection of measures and design of the questionnaire pack were 
appropriate and ‘user friendly’. Furthermore, many cancer survivors’ who contacted me 
about the study expressed their support for our research. Some included cards or notes in 
their questionnaire packs commenting on the usefulness of the research, or specific aspects 
of the questionnaire, or shared their personal cancer journey. This was very moving and 
inspiring. I felt a strong sense of support for the study from participants, in particular 
people from Macmillan Cancer Voices websites, which motivated me to work harder on 
this research. I also aim to include service users in dissemination of research findings in the 
form of a newsletter or email for research participants informing them of the latest results 
of my project. The inclusion of service users in these types of dissemination however 
requires careful planning to ensure that information is presented in an easily accessible and 
relevant form.  
 
I was very keen to involve service users in my other projects; however, none of the 
services I worked with had an active service user involvement team. This created a 
practical challenge in terms of seeking to involve users in different stages of research. 
Although I believe that there is scope for service user involvement in all-clinical research, 








 Main research project 
I sought ethical approval for my main research project through the Integrated Research 
Application System (IRAS). As I had no previous experience seeking independently IRAS 
approval, I found this process was quite complex and time-consuming. However, help 
from other trainees going through the same process was invaluable.  
I also sought Research and Development (R&D) approval from three different NHS trusts 
involved in our data collection. This process was much more straightforward compared to 
the IRAS application, with the exception of one trust that took a long time to approve the 
study. This was due to problems with their internal system for processing applications. In 
hindsight, in order to avoid such problems it would have been helpful to clarify research 
project proposals earlier on. This would have enabled me to seek ethical approval from 
IRAS earlier on, which would have then given me more time to obtain relevant R&D 
approval. In addition, I sought ethical approval from the University of Bath. This was a 
relatively straightforward process. My application form was processed in a timely fashion 
and meant that I could start data collection, and analysis as soon as the university ethics 
approval has been confirmed.  
 
 Service improvement project 
In terms of service improvement project, I sought advice from the local NHS R&D 
department regarding the level of ethical permission that was required for project. 
Following a telephone consultation with an R&D advisor, it was agreed that the project 
constituted an audit/ evaluation, as it did not involve any contact with service-users or new 
data collection apart from the one that was collected as part of the routine treatment. As 
such, ethical approval from the NHS ethics or R&D was not required for this project. Since 
this project aimed to evaluate treatment as usual that was already finished, my supervisors 
and I did not envisage any psychological or physical harm would occur as a result of the 
evaluation process and data analysis. However, I did obtain ethical approval from the 
University of Bath, as this project constituted part of my research portfolio. 
 
Recruitment and data collection  
 Service Improvement Project 
Following ethical approval from the University Ethics Committee, data analysis was 
relatively straightforward and involved the review of outcomes measures and satisfaction 
feedback collected during the study. The main difficulties in this process included analysis 
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and presentation of quantitative results, and how to combine and interpret the contrasting 
results from the qualitative and quantitative analysis. With the support and guidance from 
the supervisors, we have agreed on the most suitable analysis and we discussed what might 
be the reasons for contradicting findings from the quantitative and qualitative analysis. 
Overall, this process has helped me appreciate the value, as well as challenges, related to 
mixed methods studies. It was great to see how mixed methods design provide 
opportunities for the integration of different theoretical perspectives, and how integrating 
or combining these methods can be applied to draw on the strengths of each.  
 
 Main research project 
 Recruitment for my main research project took place across three sites in Bristol, Bath and 
Swindon. I met with all three of the teams that agreed to help with the research project. 
The teams were involved in active recruitment or advertisement of the study, and included 
nurses, doctors, and local psychologists who also acted as research supervisors and 
collaborators. Help and support from my supervisor Dr Andrew Medley was invaluable 
and instrumental in liaising with the teams and getting them on board with our research. 
Moreover, following advice from Dr Anna Lagerdahl, we added another recruitment site, 
namely the Macmillan Cancer Voices website. This helped us to maximise the number of 
people who took part in the study. Cancer voices are people from across the UK who have 
been affected by cancer in some way. They share their experiences online and help shape 
research, and other projects, aimed at improving cancer care. I was overwhelmed with the 
positive response from breast cancer survivors who contacted us through this website. As I 
already mentioned some of them shared comments on the study and the usefulness of 
research into fear of cancer recurrence. This was a highly emotional and moving 
experience. I felt privileged to be part of a research study that aims to raise awareness of 
psychological distress in cancer survivors, and promote psychological support for people 
affected by cancer. 
 
Dissemination of research knowledge  
Over the summer period I am planning to work on my research publications. In particular, 
I am aiming to submit my main research project in the Journal of Psycho-Oncology and 
my Literature review in Psychosis: Psychological, Social and Integrative Approaches. I 
hope to prepare and submit for publication some of my case study reports that received 
particularly positive feedback from course tutors and placement supervisors.  
My clinical and research experiences prior and during training confirmed how important it 
is for me to be guided in my clinical work by evidence based practice, and also to 
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contribute to it. I believe that effective dissemination can support health care professionals 
to share information about clinical developments, and help services and individual 
practitioners implement innovative approaches.  
 
Future involvement in research and service development 
During my training, I have developed a strong foundation of post-graduate research, and 
further increased my interest in service development projects. Although I understand that 
many psychology jobs do not include time for research, I am planning to maintain research 
activity and involvement in various service improvement projects throughout my career in 
Clinical Psychology. In particular, I have already looked for opportunities to get involved 
in training events, organised by the British Psychological Society and Division of Clinical 
Psychology, aimed to promote research involvement for clinical psychologists early on in 
their career. I would also like to find ways of collaborating and contributing to other 




Implications for career and future practice 
Having enjoyed most of my clinical placements, I am keen to pursue a very wide range of 
jobs. Despite my specific interests in clinical health psychology and complex adult mental 
health, I would be keen to purse a range of different jobs in areas of child and adolescent 
mental health and older adults services. The breadth of my research and professional 
portfolio supports this, as the differing topics will be applicable to a variety of fields. I also 
feel that the variety of research projects I have carried out during my training puts me in a 
good position to be able to contribute to research, and service development post-
qualification. 
 
The art and science of clinical knowledge 
I was attracted to the Bath course as it encourages the development of specialist knowledge 
in psychological theory, and evidence based treatment, and shows how it can be applied to 
practice through paying close attention to the core values of Clinical Psychology.  In 
particular, during my training I was inspired to learn from many experts in clinical 
psychology, and great clinicians working in the NHS, who illustrated to me how to 
skillfully integrate the ‘clinical science’ of psychology, with ‘clinical art’ that emphasizes 
reflective practice, person-centered, and culturally sensitive approaches. I am inspired to 
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(A) Appendices for Literature Review 
Appendix A1. Instructions for authors 
 
Instructions for authors and brief reasons for choosing this journal 
Psychosis: Psychological, Social and Integrative Approaches is a new journal that accepts 
original articles related to research on the psychological treatments of psychosis, and the 
psycho-social causes of psychosis. The journal publishes papers on both quantitative and 
qualitative research, as well as papers focusing on conceptual and ethical issues. This 
journal was chosen as its aims and scope relates directly to the topic of the critical review 
of the literature. 
 
General guidelines for manuscript preparation 
 Manuscripts should be consistent with the Aims and Scope of the journal. 
 Research articles and reviews should not exceed 5,000 words. 
 Abstract of 200 words is required for all manuscripts submitted. 
 Each paper should have up to five keywords 
 Section headings should be concise. 
 A subsection subtitled Clinical Implications is required in Discussion. 
 Tables should be numbered consecutively with Arabic numbers in order of 
appearance in the text. Type each table double-spaced on a separate page, with a 
short descriptive title typed directly above and with essential footnotes below. 










(B) Appendices for Service Improvement Project 
Appendix B1. Instructions for authors 
 
Instructions for authors and brief reasons for choosing this journal  
 
Comprehensive Psychiatry provides a forum for clinicians and investigators of markedly 
divergent concepts, methods and orientations. Clear, concise reports cover developments in 
clinical and basic investigations as well as new diagnostic and therapeutic practices. 
 
General guidelines for manuscript preparation 
 Manuscripts should be consistent with the Aims and Scope of the journal. 
 Each paper should have up to six keywords 
 The text should be in single-column format with the layout of the text as simple as 
possible.  
 Article should be divided into clearly defined and numbered sections. 
 Any subsection may be given a brief heading. Each heading should appear on its 
own separate line. 
   A structured abstract, by means of appropriate headings, should provide the 
context or background for the research and should state its purpose, basic 
procedures (selection of study subjects or laboratory animals, observational and 
analytical methods), main findings (giving specific effect sizes and their statistical 
significance, if possible), and principal conclusions. It should emphasize new and 
important aspects of the study or observations. 
 Highlights are mandatory for this journal. They consist of a short collection of 
bullet points that convey the core findings of the article and should be submitted in 
a separate editable file in the online submission system. 'Highlights' should include 
3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point). 
 Introduction - State the objectives of the work and provide an adequate 
background, avoiding a detailed literature survey or a summary of the results. 
 Material and methods - Provide sufficient detail to allow the work to be 
reproduced. Methods already published should be indicated by a reference: only 
relevant modifications should be described. 
 Results   Results should be clear and concise. 
 Discussion - This should explore the significance of the results of the work, not 
repeat them. A combined Results and Discussion section is often appropriate. 
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Avoid extensive citations and discussion of published literature. 
 Conclusions - The main conclusions of the study may be presented in a short 
Conclusions section, which may stand alone or form a subsection of a Discussion 
or Results and Discussion section. 
 Reference style - Indicate references by superscript numbers in the text. The actual 
authors can be referred to, but the reference number(s) must always be given.  List: 
Number the references in the list in the order in which they appear in the text.   










































STEPPS Treatment Evaluation Survey  
 
Please help us improve our service by answering some questions about the treatment you 
have received in the Systems Training for Emotional Predictability and Problem 
Solving (STEPPS) group treatment. We are interested in your honest opinions, whether 
they are positive or negative. Please answer all of the questions. We also welcome your 
comments and suggestions. Thank you very much, we appreciate your help. Please circle 
your answer. 
 
1. “I attended more than half of the sessions”  
 1                           2                          3      4                      5 
 Strongly Disagree        Disagree             Neutral            Agree            Strongly Agree 
 
2. “I was given a very clear explanation of what BPD means”  
 1                           2                          3      4                      5 
 Strongly Disagree        Disagree             Neutral            Agree            Strongly Agree 
 
3. “I did not find the manual helpful”  
 1                           2                          3      4                      5 
 Strongly Disagree        Disagree             Neutral            Agree            Strongly Agree 
 
4. “The sessions were very helpful, and taught me how to handle difficulties better”  
 1                           2                          3      4                      5 
 Strongly Disagree        Disagree             Neutral            Agree            Strongly Agree 
 
5. “The skills I learned are highly effective”  
 1                           2                          3      4                      5 
 Strongly Disagree       Disagree             Neutral            Agree            Strongly Agree 
 
6. “Skill cards helped me to explain my illness to others”  
 1                           2                          3      4                      5 
 Strongly Disagree        Disagree             Neutral            Agree            Strongly Agree 
 
7. “After STEPPS, people say I have fewer problems”  
 1                           2                          3      4                      5 
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 Strongly Disagree        Disagree             Neutral            Agree            Strongly Agree 
 
8. “After STEPPS, I have been much less likely to harm myself”  
 1                           2                          3      4                      5 
 Strongly Disagree        Disagree             Neutral            Agree            Strongly Agree 
 
9. “Amount of materials”  
 1                           2                          3       4                     5 
      Too little                  Little                 Enough            Much             Too much 
10. “Time to discuss my intense emotions” 
       1                           2                          3                      4                     5 
      Too little                  Little                 Enough            Much             Too much 
11. “Length of sessions”  
 1                           2                          3       4                     5 
      Too little                  Little                 Enough            Much             Too much 
12. “Number of sessions” 
 1                           2                          3       4                     5 
      Too little                  Little                 Enough            Much             Too much 
13. “Time provided to learn new skills” 
 1                           2                          3       4                     5 
      Too little                  Little                 Enough            Much             Too much 
 























Appendix B3. Information relevant to ethical review 
 
The Service Improvement Project received approval from The University of Bath Research 
Ethics Committee (reference number 13-161). In the absence of a formal letter, please 
contact psychology-ethics@bath.ac.uk for further information. 
(C) Appendices for Main research project 
Appendix C1. Instructions for authors  
 
 Manuscript Submission - All papers must be submitted via the online system. 
Psycho-Oncology operates an online submission and peer review system that 
allows authors to submit articles online and track their progress via a web interface. 
 Copyright and Permissions - If your paper is accepted, the author identified as the 
formal corresponding author for the paper will receive an email prompting them to 
login into Author Services; where via the Wiley Author Licensing Service (WALS) 
they will be able to complete the license agreement on behalf of all authors on the 
paper. 
 Submission of a manuscript will be held to imply that it contains original 
unpublished work and is not being submitted for publication elsewhere at the same 
time. Submitted material will not be returned to the author, unless specifically 
requested. 
 Manuscript style. The language of the journal is English. 12-point type in one of the 
standard fonts: Times, Helvetica, or Courier is preferred. It is not necessary to 
double-line space your manuscript. There should be a separate title page with full 
information and another page for an abstract, prior to the Introduction. Tables must 
be on separate pages after the reference list, and not be incorporated into the main 
text. Figures should be uploaded as separate figure files. 
 During the submission process you must enter the full title, short title of up to 70 
characters and names and affiliations of all authors. Give the full address, including 
email, telephone and fax, of the author who is to check the proofs.  Include the 
name(s) of any sponsor(s) of the research contained in the paper, along with grant 
number(s). 
 Enter an abstract of up to 250 words for all articles. An abstract is a concise 
summary of the whole paper, not just the conclusions, and is understandable 
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without reference to the rest of the paper. It should contain no citation to other 
published work. You must submit your abstract according to these headings: 
objective; methods; results; conclusions.  
 Include up to six keywords which must contain the words cancer and oncology that 
describe your paper for indexing purposes.  
 Research Articles should not exceed 4000 words (including no more than four 
figures and/or tables) plus up to 40 references. Review papers of up to 6000 words 
will be considered, with 80 references - authors should contact the Editors for 
advice. All papers should use the following headings: Background, Methods 
(including statistical methods), Results, Conclusions. Word counts should include 
the title page, abstract, main manuscript, tables and figures, but exclude the 
references.  
 Qualitative manuscript submissions should usually be based on a minimum of 20 
respondents. Authors may contact the Editors if they require further details.  
 Reference style. References should be cited in the text by number within square 
brackets and listed at the end of the paper in the order in which they appear in the 
text. All references must be complete and accurate. If necessary, cite unpublished 
or personal work in the text but do not include itin the reference list. Where 
possible the DOI for the reference should be included at the end of the reference. 
Online citations should include date of access. References should be listed in the 
following style: Decker, CL. Social support and adolescent cancer survivors: A 
review of the literature. Psycho-Oncology 2007; 16 : 1-11. Peterson AC, Leffert N. 
What is special about adolescence? In Psychosocial Disturbances in Young People: 
Challenges for Prevention, Rutter M (ed.).Cambridge University Press: Cambridge, 
1997;3-36. 
 Tables should be part of the the main document and should be placed after the 
references. If the table is created in excel the file should be uploaded separately. 
 Ethics. Authors of research papers should provide information about funding, a 
Conflict of Interest statement, details of ethical committee review, and (if the paper 
is a clinical trial) details of trial registration. All of these declarations should be in 
the research paper itself, not a covering letter. If authors include named individuals 
in the Acknowledgements they must confirm that they have approval from those 
individuals in their covering letter 
 Post Acceptance. Further Information. For accepted manuscripts the publisher will 
supply proofs to the submitting author prior to publication. This stage is to be used 
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only to correct errors that may have been introduced during the production process. 
Prompt return of the corrected proofs, preferably within two days of receipt, will 
minimise the risk of the paper being held over to a later issue. Free access to the 














































Appendix C2. Measures used 
 




     
     
     







Thank you for kindly agreeing to take part in this study.   
 
Worry and anxiety after treatment for cancer is very common and entirely normal and 
understandable.  These worries can include fears about the risk of cancer returning in the 
future, which can become quite troublesome and disruptive for some people.   
 
Your answers to this questionnaire will help us to better understand factors related to 
intrusive or persistent fear about cancer recurrence.  These new insights should then help 
us to design and provide more effective and timely psychological and emotional support, 
as an integral part of cancer care services in this region and beyond.   
 
The questionnaire will take about 15 to 20 minutes to complete. If you have any 
questions regarding this study, then please contact us using details provided in the 
information sheet.  We very much appreciate your help in taking time to complete this 
questionnaire. 
 
With our best wishes, 
 







This questionnaire is asking about a general tendency to worry about one’s health, so the questions 
do not necessarily relate to worries about cancer. 
 
Each question consists of a group of four statements.  Please read each group of statements carefully 
and then select the one which best describes your feelings, over the past three months.  Identify the 
statement by circling the letter next to it, i.e. if you think that statement a. is correct, circle statement 
a. It may be that more than one statement applies, in which case, please circle any that are 
applicable. 
 
1   a. I do not worry about my health 
b. I occasionally worry about my health 
c. I spend much of my time worrying about my health 
d. I spend most of my time worrying about my health 
 
2  a. I notice aches/pains less than most other people (of my age) 
b. I notice aches/pains as much as most other people (of my age) 
c. I notice aches/pains more than most other people (of my age) 
d. I am aware of aches/pains in my body all the time 
 
3  a. As a rule I am not aware of bodily sensations or changes 
b. Sometimes I am aware of bodily sensations or changes 
c. I am often aware of bodily sensations or changes 
d. I am constantly aware of bodily sensations or changes 
 
4  a. Resisting thoughts of illness is never a problem 
b. Most of the time I can resist thoughts of illness 
c. I try to resist thoughts of illness but am often unable to do so 
d. Thoughts of illness are so strong that I no longer even try to resist them 
 
5  a. As a rule I am not afraid that I have a serious illness 
b. I am sometimes afraid that I have a serious illness 
c. I am often afraid that I have a serious illness 
d. I am always afraid that I have a serious illness 
 
6  a. I do not have images (mental pictures) of myself being ill 
b. I occasionally have images of myself being ill 
c. I frequently have images of myself being ill 
d. I constantly have images of myself being ill 
 
7 a. I do not have any difficulty taking my mind off thoughts about my health 
b. I sometimes have difficulty taking my mind off thoughts about my health 
c. I often have difficulty in taking my mind off thoughts about my health 
d. Nothing can take my mind off thoughts about my health 
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8  a. I am lastingly relieved if my doctor tells me there is nothing wrong 
b. I am initially relieved but the worries sometimes return later 
c. I am initially relieved but the worries always return later 
d. I am not relieved if my doctor tells me there is nothing wrong 
 
9  a. If I hear about an illness I never think I have it myself 
b. If I hear about an illness I sometimes think I have it myself 
c. If I hear about an illness I often think I have it myself 
d. If I hear about an illness I always think I have it myself 
 
10  a. If I have a bodily sensation or change I rarely wonder what it means 
b. If I have a bodily sensation or change I often wonder what it means 
c. If I have a bodily sensation or change I always wonder what it means 
d. If I have a bodily sensation or change I must know what it means 
 
11  a. I usually feel at very low risk for developing a serious illness 
b. I usually feel at fairly low risk for developing a serious illness 
c. I usually feel at moderate risk for developing a serious illness 
d. I usually feel at high risk for developing a serious illness 
 
12  a. I never think I have a serious illness 
b. I sometimes think I have a serious illness 
c. I often think I have a serious illness 
d. I usually think that I am seriously ill 
 
13  a. If I notice an unexplained bodily sensation I don't find it difficult  
to think about other things 
b. If I notice an unexplained bodily sensation I sometimes find it difficult  
to think about other things 
c. If I notice an unexplained bodily sensation I often find it difficult  
to think about other things 
d. If I notice an unexplained bodily sensation I always find it difficult  
to think about other things 
 
14  a. My family/friends would say I do not worry enough about my health 
b. My family/friends would say I have a normal attitude to my health 
c. My family/friends would say I worry too much about my health 









Emotional Reactions to Difficult Circumstances 
 
This questionnaire is about how you feel currently in relation to your experience of cancer.  
In the following, you will find a number of statements that describe thoughts and feelings that 
people sometimes experience in the face of serious illness or symptoms.  Please rate the extent to 
which these statements apply to your experience at present by circling the appropriate number.  
There are no right or wrong answers to these questions.  Please remember that this questionnaire 
is about how you feel and think at present.  
   
Because of cancer… 
Not at all / 
Never 
Very little Moderately Strongly 
Very 
strongly 
1 I feel defeated by life………………………..  0 1 2 3 4 
2 
I feel that I have lost my standing in 
the world…………………………………………. 
0 1 2 3 4 
3 
I feel that life has treated me like a 
punchbag…………………………………………. 
0 1 2 3 4 
4 I feel powerless……………………………….. 0 1 2 3 4 
5 
I feel that my confidence has been 
knocked out of me…………………………… 
0 1 2 3 4 
6 
I don’t feel able to deal with things 
that life throws at me……………………… 
0 1 2 3 4 
7 
I feel that I have sunk to the bottom 
of the ladder……………………………………. 
0 1 2 3 4 
8 
I feel completely knocked out of 
action………………………………………………. 
0 1 2 3 4 
9 I feel that I am one of life’s losers……. 0 1 2 3 4 
10 I feel that I have given up………………… 0 1 2 3 4 
11 I feel down and out………………………….. 0 1 2 3 4 
12 
I feel I have lost important battles in 
life……………………………………………………. 
0 1 2 3 4 
13 I feel that there is no fight left in me.. 0 1 2 3 4 
14 I feel I am losing my will power………… 0 1 2 3 4 
15 
I don’t care what happens to me 
anymore………………………………………….. 
0 1 2 3 4 
16 I feel defeated…………………………………. 0 1 2 3 4 
17 I feel less like a human being…………… 0 1 2 3 4 
18 In my mind, I give up……………………….. 0 1 2 3 4 
19 I feel destroyed as a person……………… 0 1 2 3 4 
20 I feel like I want to die……………………… 0 1 2 3 4 
21 
I feel like I am losing my inner 
resistance………………………………………… 
0 1 2 3 4 
22 I feel like an object…………………………… 0 1 2 3 4 
23 
I feel completely at the mercy of 
what is happening to me…………………. 
0 1 2 3 4 
24 
I feel humiliated and that I am losing 
my sense of inner dignity…………………. 





How I typically act towards myself in difficult times… 
 
Please read each statement carefully before answering. To the left of each item, indicate how 
often you behave in the stated manner, using the following scale:  
 
Almost never       Almost always 
1  2    3    4    5 
 
 
      When I fail at something important to me I become consumed by feelings of inadequacy. 
  I try to be understanding and patient towards those aspects of my personality I don’t like. 
  When something painful happens I try to take a balanced view of the situation. 
  When I’m feeling down, I tend to feel like most other people are probably happier than I am. 
  I try to see my failings as part of the human condition. 
  When I’m going through a very hard time, I give myself the caring and tenderness I need. 
  When something upsets me I try to keep my emotions in balance. 
  When I fail at something that’s important to me, I tend to feel alone in my failure 
  When I’m feeling down I tend to obsess and fixate on everything that’s wrong. 
  When I feel inadequate in some way, I try to remind myself that feelings of inadequacy are 
shared by most people. 
  I’m disapproving and judgmental about my own flaws and inadequacies. 














Worry about cancer 
 
Most people who have been diagnosed with cancer are worried, to varying degrees, that there 
might be a recurrence of the cancer.  By recurrence, we mean the possibility that the cancer 
could return or progress in the same place or in another part of the body.  This questionnaire 
aims to better understand the experience of worries about cancer recurrence.  Please read each 
statement and indicate to what degree it applied to you during the past month by circling the 
appropriate number. 
 
1. I am worried or anxious about the possibility of cancer recurrence. 
0  Not at all 1  A little 2  Somewhat 3  A lot 4  A great deal 
 
2. I am afraid of cancer recurrence.      
0  Not at all 1  A little 2  Somewhat 3  A lot 4  A great deal 
 
3. I believe it is normal to be worried or anxious about the possibility of cancer recurrence. 
0 Not at all 1 A little 2  Somewhat 3  A lot 4  A great deal 
 
4. When I think about the possibility of cancer recurrence, this triggers other unpleasant thought  
or images (such as death, suffering, the consequences for my family). 
0  Not at all 1  A little 2  Somewhat 3  A lot 4  A great deal 
 
5. I believe that I am cured and that the cancer will not come back. 
0  Not at all 1  A little 2  Somewhat 3  A lot 4  A great deal 
 
6. In your opinion, are you at risk of having a cancer recurrence? 
0  Not at all at 
risk 
1  A little at 
risk 
2  Somewhat 
at risk 
3  A lot at risk 4  A great deal 
at risk 
 
7. How often do you think about the possibility of cancer recurrence? 
0  Never 1  A few times 
a month 
2  A few times 
a week 
3  A few times a day 4  Several times a 
day 
 
8. How much time per day do you spend thinking about the possibility of cancer recurrence? 
0  I don’t think 
about it 
1  A few 
seconds 
2  A few 
minutes 
3  A few hours 4  Several hours 
 
9. How long have you been thinking about the possibility of cancer recurrence? 
0  I don’t think 
about it 
1  A few 
weeks 
2  A few 
months 









PHQ-9 Mood questionnaire 
 
 
  Over the last 2 weeks, how often have you  
  been bothered by any of the following problems? 


















Nearly       
every 
 day 
1. Little interest or pleasure in doing things. 0 1 2 3 
2. Feeling down, depressed, or hopeless. 0 1 2 3 
3. Trouble falling or staying asleep, or sleeping too much. 0 1 2 3 
4. Feeling tired or having little energy. 0  1 2 3 
5. Poor appetites or overeating. 0 1 2 3 
6. Feeling bad about yourself – or that you are a failure or 
have let yourself or your family down. 
0 1 2 3 
7. Trouble concentrating on things, such as reading the 
newspaper or watching television. 
0 1 2 3 
8. Moving or speaking so slowly that other people could 
have noticed?  Or the opposite — being so fidgety or 
restless that you have been moving around a lot more 
than usual. 
0 1 2 3 
9. Thoughts that you would be better off dead,  
or of hurting yourself. 
0 1 2 3 
 
If you checked off any problems, how difficult have these problems made it for you to do your work, 
take care of things at home, or get along with other people? 
 





















































  Over the last 2 weeks, how often have you   
  been bothered by the following problems? 











1.  Feeling nervous, anxious or on edge 0 1 2 3 
2.  Not being able to stop or control worrying 0 1 2 3 
3.  Worrying too much about different things 0 1 2 3 
4.  Trouble relaxing 0 1 2 3 
5.  Being so restless that it is hard to sit still 0 1 2 3 
6.  Becoming easily annoyed or irritable 0 1 2 3 
7.  Feeling afraid as if something awful  
     might happen 
0 1 2 3 
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Health-related coping behaviours 
 
This section will help us to understand the types of coping strategies that you employ in relation 
to monitoring your health and wellbeing.  
 
1. In the past 12 months, how many times have you visited your GP or Oncologist/Specialist Nurse 
to discuss potential symptoms of recurrence over and above your routine follow-up 
appointments?  
 
Number of GP visits: 
 (Please specify) 
Number of Oncologist or Special Nurse visits:  
(Please specify) 
 
2. In the past 12 months, how many times have you visited your GP for any reason?  
Please tick the appropriate box below  ✓ 
 
Not at all Rarely  
(up to 6 times) 
Monthly Fortnightly Weekly 
     
 
3. What is the average frequency of your self-examination of your breasts or other parts of the 
body? Please tick the appropriate box below  ✓ 
 
Not at all A few times 
per year 
Monthly Weekly Daily Several times 
per day 
      
 
4. To what extent do you use Internet searches to seek out information related to your diagnosis 
of cancer and the risk of recurrence in the future?  Please tick the appropriate box below  ✓ 
 
Not at all A few times 
per year 
Monthly Weekly Daily Several times 
per day 
      
 
5. To what extent do you seek verbal reassurance from people around you (e.g. family, friends, 
other people affected by cancer, or your healthcare team) in relation to your diagnosis of cancer 
and the risk of recurrence in the future?  Please tick the appropriate box below  ✓ 
 
Not at all A few times 
per year 
Monthly Weekly Daily Several times 
per day 









Demographic and treatment information 
 
Age:    
   
Date of diagnosis:   
 
Date of completion of chemotherapy or radiotherapy treatment (whichever later):   
 























Thank you so much for your time and taking part in this study. 
 
With our best wishes, 




Please read the following advice carefully:  
 
If you feel upset or distressed as a result of completing this questionnaire, then please don’t 
hesitate to contact a member of the research team (using the contact details on the Participant 
Information Sheet) or your Specialist Nurse to talk things through.   
 
If your answers to any of the questions in this form indicate that you are experiencing thoughts 
about harming yourself, then please consider contacting your GP, Specialist Nurse, or other member 
of your healthcare team without delay to discuss options for further support.  If these answers lead 
us to feel especially concerned about your wellbeing, then we will discuss this with your Oncology 
team so that they can make contact with you and your GP to discuss your preferences and needs for 
additional support.       
 
If you feel the need to speak with somebody urgently, then please consider contacting the 





Study of health anxiety in cancer recovery  
(Ania Grozdziej & Dr Andrew Medley, University of Bath) 
 
 
Please answer each of the following questions by ticking  the relevant check boxes. 
 
Please then return the form to the University of Bath in the Freepost envelope provided.  
 
           
 
Please tick  the relevant check boxes for each of the following questions: 
 
 









2. What is your highest educational 
qualification? 
 
No formal qualification☐ 
Primary☐ 
Secondary (e.g. GCSE, O-Levels, GNVQ)☐ 






3. What is your relationship status?                  
(tick all boxes that apply) 
 
Single☐ 










4. What is your employment situation?        










Thank you very much for taking the time to complete and return this form. 
 
With our best wishes, 
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